Embed Size (px)
Citation preview
The love of learning, the sequestered nooks, And all the sweet serenity ofbooks
- Henry Wadsworth Longfellow
References
References
1. Oldach DW. Richard RE, Borza EN, Benitez RM. A mysterious death. N Engl J
Med 1998;338(24): 1764-9
2. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World
Health Organ 2004;82(5):346-53
3. Forsyth JRL. Typhoid and paratyphoid. In: Collier L, Balow A, Sussman M,
editors. Topley and Wilsons' microbiology and microbial infections. 9'h Ed. Great
Britain: Arnold; 1998. p. 459-78
4. Levine MM, Stein MB. Shigella, Salmonella typhi and Escherichia coli: effects of
microbes on the immune system. In: Cunningham MW. Fujinami RS, editors.
Effects of microbes on the immune system. Phi1adelphia:Lippincott Williams and
Wilkins; 2000.p. 171-94
5 . Murray PR, Baron El, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of
clinical microbiology. 7Ih Ed. Washington DC: ASM Press; 1999
6. Yu VL, Merigan TC Jr. B.*rriere SL, editors. Antimicrobial therapy and vaccines.
Baltimore (Maryland): William & Wilkins; 1999
7. Bitar R. Tarpley I. Intestinal perforation in typhoid fever: a historical and state-of-
the-art review. Rev Infect Dis 1985:7(2):2.57-7 1
8. Nelson KE. Early history of infectious diseaae- epidemiology and control of
infectious disease. In: Nelson KE, William CM. Graham NMH, editors. Infectious
Disease Epidemiology- Theory and Practice. Maryland: Aspen Publications Inc;
2M)I. p. 3-15
9. Lee TP. Hoffman SL, Typhoid fever. In: Strickland GT, editor. Hunters tropical
medicine and emerging infectious disease. 8" Ed. Philadelphia: WB Saunders Co;
2000. p. 47 1-84
10. Ivanoff B, k v i n e MM. Typhoid fever: continuing challenges from a resilient
bacterial foe. Bull Inst Pasteur 1997;95:129-42
I I. Miller IS. Pegues DA. Salmonella species, including Salmonella cyphi. In:
Mandell GL, Bennett JE, Dolin R, editors. Mandell. Douglar and Bennetts
References
principles and practice of infectious disease. 5Ih Ed. Philadelphia: Churchill
Livingstone; 2000. p. 2344-63
12. Baumler AJ, Tsolis RM, Ficht TA. Adams LG. Evolution of host adaptation in
Salmonella enterica. lnfect lmmun 1998;66(10):4579-87
13. Kidgell C. Reichard U, Wain J, Linz B, Torpdahl M, Dougan G, Achtman M.
Salmonella typhi, the causative agent of typhoid fever, is approximately 50,000
years old, lnfect Genet Evol2002;2(1):39-45
14. Parkhill J, Dougan G, James KD. Thomson NR, Pickard D. Wain J,et al.
Complete genome sequence of a multiple drug resistant Salmonella enterica
serovar Typhi CT18. Nature 2001 ;413(6858):848-52
15. McClelland M. Sanderson KE, Clifton SW, Latreille P, Ponvollik S, Sabo A, et
al. Comparison of genome degradation in Paratyphi A and Typhi, human-
restricted serovars of Salmonella enterica that cause typhoid. Nat Genet
2004;36( 12): 1268-74
16. Thomson N. Baker S. Pickard D, Fookes M, Anjum M, Hamlin N, et al. The role
of prophage-like elements in the diversity of Salmonella enterica serovars. J Mol
Biol2004;339(2):279-300
17. Calva E. Ordonez LG, Fernandez-Mora M. Santana FJ, Bobadilla M, Puente JL.
Distinctive IS200 insertion between gyrA and rcsC genes in Salmonella typhi. J
Clin Micmbiol 1997;35(12):3048-53
18. Deng W, Liou SR, Piunkett G 3rd. Mayhew GF, Rose DJ, Burland V, et al.
Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and
CT18.J Bacterial 2003; 185(7):2330-7
19. Boyd EF. Ponvollik S, Blackmer F, McClelland M. Differences in gene content
among Salmonella enterica serovu typhi isolates. J Clin Microbial
2003;41(8):3823-8
20. Kidgell C, Pickard D, Wain J, James K, Diem Nga LT, Diep TS, et a].
Characterisation and distribution of a cryptic Salmonella typhi plasmid pHCM2.
Plasmid 2002;47(3): 159-7 1
21. Reeves M W, Evins G M, Heiba A A, Plikaytis B D, Farmer J J 111. Clonal nature
of Salmonella typhi and is genetic relatedness to other salmonellae as shown by
References
multilocus enzyme electrophoresis, and proposal of Salmonella bongori comb.
nov. J Clin Microbiol 1989;27:313-20
22. Selander RK, Beltran P, Smith NH, Helmuth R, Rubin FA, Kopecko DJ, et al.
Evolutionary genetic relationships of clones of Salmonella serovars that cause
human typhoid and other enteric fevers. Infect Immun 1990;58:2262-75
23. Fica AE, Prat-Miranda S, Fernandez-Ricci A, D'Ottone K, Cabello FC. Epidemic
typhoid in Chile: analysis by molecular and conventional methods of Salmonella
typhi strain diversity in epidemic (1977 and 1981) and nonepidemic (1990) years.
J Clin Microbiol 1996:34(7): 1701-7
24. Thong KL, Puthucheary SD. Pang T. Genome size variation among recent human
isolates of Salmonella typhi. Res Microbiol 1997; 148(3):229-35
2 5 . Thong KL, Goh YL. Yasin RM. h u MG, Passey M, Winston G, et al. Increasing
genetic diversity of Salmonella enterica serovar typhi isolates from Papua New
Guinea over the period from 1992 to 1999. J Clin Microbiol 2002;40( 11):4156-60
26. Pang T. Genetic dynamics of Salmonella typhi--diversity in clonality. Trends
Microbiol 1998;6(9):339-42
27. Liu SL, Sanderson KE. Highly plastic chromosomal organization in Salmonella
typhi. Proc Natl Acad Sci U S A 1996;93(19):10303-8
?I. Liu SL, Sanderson KE. Rearrangements in the genome of the bacterium
Salmonella typhi. Roc Natl Acad Sci U S A 1995;92(4):1018-22
29. Salmonella. In: Cruickshank R, Deguid JP, Marimion BP, Swain RHA, editors.
Medical microbiology: the practice of medical microbiology. 12' Edn.
Edinburgh: Churchill Livingstone; 1975. p 221-237
30. Quintiies BR. Leal NC. Reis EM, Fonseca EL. Hofer E. Conventional and
molecular typing of Salmonella typhi strains from Brazil. Rev lnst Med Trop Sao
Paulo 2002;44(6):3 15-9
31. Thong KL, Cheong YM, Puthucheiuy S, Koh CL. Pang T. Epidemiologic analysis
of sporadic Salmonella typhi isolates and those from outbreaks by pulsed-field gel
electrophoresis. J Clin Microbiol 1994;32(5): 1 135-41
References
32. Tian K, Kan B, HU W, Tong Y, Lu T. [Diversity of 16s rDNA ribotypes of the
Salmonella typhi strains isolated in Guizhou province] Zhonghua Liu Xing Bing
Xue Za Zhi 2002;23(1):50-3
33,Hermans PW, Saha SK, van Leeuwen WJ, Verbrugh HA, van Belkum A,
Goessens WH. Molecular typing of Salmonella typhi strains from Dhaka
(Bangladesh) and development of DNA probes identifying plasmid-encoded
multidrug-resistant iso1ates.J Clin Microbiol 1996;34(6): 1373-9
33. Liu Y, Lee MA, Ooi EE, Mavis Y, Tan AL. Molecular typing of Salmonella
enterica serovar typhi isolates from various countries in Asia by a multiplex PCR
assay on variable-number tandem repeats. J Clin Microbiol 2003;41(9):4388-94
35. Nair S, Schreiber E. Thong KL, Pang T, Altwegg M. Genotypic characterization
of Salmonella typhi by amplified fragment length polymorphism fingerprinting
provides increa~ed discrimination as compared to pulsed-field gel electrophoresis
and ribotyping. J Microbiol Methods 2000;41(1):35-43
36. Kingsley RA. Baumler AJ.Host adaptation and the emergence of infectious
diseaw: the Salmonella paradigm.Mol Microbiol 2000;36(5): 1006-14
37. Parry CM. Typhoid Fever. Curr Infect Dis Rep 2004:6(1):27-33
38. Shere KD, Goldberg MB. Rubin RH. Salmonella Infections. 1n:Gorbach RL,
Btlrtlett JG, Blacklow NR (Eds.) Infectious diseases. 2" a n . Philadelphia: WB
Saunders Company; 1998. p. 699-7 12
39. Ga\ern MH. Dolmans WM. Keuter MM, Djokomoeljanto RR. Poor food hygiene
and housing as risk factors for typhoid fever in Sernarang, Indonesia. Trop Med
Int Health 200 1 ;6(6):484-90
40. Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah VP, Singh B, et al. Typhoid
fever in children aged less than 5 years. Lancet 1999; 354: 734-37
4I.Lin FY. Vo AH, Phan VB, Nguyen 7T, Bryla D, Tran CT, et al. Tbe
epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region
of Vietnam. Am J Trop Med Hyg 2000;62(5):644-8
42. Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet
2005;366(9487):749-62
References
43. Prevalence and Incidence of Typhoid fever-WrongDiagnosis.com downloaded
from http:llwww.wrongdiagnosis.com~t~typhoid~fever/prevaencehtm on
26.03.06
44. Brooks WA. Hossain A, Goswami D, Nahar K, Alam K, Ahmed N, et al.
Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg Infect
Dis 2005: 1 1 (2):326-9
45. Background document: The diagnosis, treatment and prevention of typhoid fever
downloaded from
http://www.who.int/vaccine~re\earch/documentsletyphoiddiagnosispdf on
26.03.06
46. Clegg A, Passey M, Omena M. Karigifa K, Suve N. Re-evaluation of the Widal
agglutination test in response to the changing pattern of typhoid fever in the
highlands of Papua New Guinea. Acta Trop 1994;57(4):255-63
47. Lin M, Dong B, Tang 2. Gong J , Li C. Wang M, et al. Analysis of data on
surveillance of typhoid and paratyphoid fever in Guangxi, 2001-4 Roceedings of
the 6' International Conference on Typhoid Fever and Other Salmonelloses.
2005, November 12-14; Guilin, China
48. Siddiqui FJ. Rabbani F, Hwan R, Nizami SQ, Bhutta ZA. Typhoid fever in
children: some epidemiological considerations from Karachi, Pakistan. Int J lnfect
Dis 2006; 10(3):2 15-22
4Y, Stock 1. Wiedemann 8. Naturil antibiotic susceptibility of Salmonella enterica
swains. Int I Antimicrob Agents 2000; 16(3):2 1 1-7
50. Olane J, Galindo E. Salmonella typhi resistant to chloramphenicol, ampicillin,
and other antimicrobial agents: strains isolated during an extensive typhoid fever
epidemic in Mexico. Antimicrob Agents Chemother 1973:4(6):597-60 1
5l.Panicker CKJ. Vimala KN. Transferable chlorarnphenicol resistance in
Salmonella typhi. Nature 1972;239: 109-1 I0
52. Brown JD. Duong Hong M, Rhoades ER.Chloramphenicol-resistant Salmonella
typhi in Saigon, JAMA 1975;23 l(2): 162-6
53.Rowe B, Ward LR, Threlfall EJ. Multidmg-resistant Salmonella typhi: a
worldwide epidemic. Clin lnfect Dis 1997;24 Suppl I:S106-Y
References
54. Schwalbe RS, Hoge CW, Morris JG Jr, O'Hanlon PN, Crawford RA, Gilligan PH.
In vivo selection for transmissible drug resistance in Salmonella typhi during
antimicrobial therapy. Antimicrob Agents Chemother 1990;34(1):161-3
55. Wain J, Kidgell C. The emergence of multidmg resistance to antimicrobial agents
for the treatment of typhoid fever. Trans R Soc Trop Med Hyg 2004;98(7):423-30
56. Kohbata S, Takahashi M, Yabuuchi E. Lactose-fermenting, multiple drug-
resistant Salmonella typhi strains isolated from a patient with postoperative
typhoid fever. J Clin Microbiol 1983; 18(4):920-5
.57. Smith HW, Parsell Z. Green P. Thermosensitive HI plasmids determining citrate
utilization. J Gen Microhiol 1978:109(2):305-1 1
58. Toro CS, Lobos SR. Calderon I, Rodriguez M, Mora GC. Clinical isolate of a
parinless Salmonella typhi resistant to high levels of chloramphenicol.
Antimicrob Agents Chemother 1990;34(9): 17 15-9
59. Beeching NJ. Hart CA, Duerden BI. Tropical and exotic infections. Proceedings
of the 5th Liverpool Tropical School Bayer Symposium on Microbial Diseases.
14 February 1998. J Med Microbiol 2000;49(1):5-27
60. Deshmukh CT. Ndkarni UB, K m d e SC. An analysis of children with typhoid
fever admitted in 199 1. J Postgrad Med 1994;40(4):204-7
61. Koul PB. Murali MV, Shanna PP, Ghai OP, Ramchandran VG, Talww V.Multi
drug resistant Salmonella typhi infection: clinical profile and therapy, Indian
Pediatr 199 1;28(4):357-6 1
62. Taylor DE. Churnpitar JC, Goldstein F. Variability of IncHIl plasmids from
Salmonella typhi with special reference to Peruvian plasmids encoding
resistance to trimethoprim and other antibiotics.
Antimicrob Agents Chemother 1985;28(3):452-5
63. Sherbume CK. Lawley TD. Gilmour MW, Blanner FR, Burland V, Grotbeck E, et
al. The complete DNA sequence and analysis of R27, a large lncH1 plasmid from
Salmonella typhi that is temperature sensitive for transfer. Nucleic Acids Res
2000;28(10):2 177-86
References
64. Tassios IT. Vatopoulos AC, Mainas E, Gennimata D, Papadakis J, Tsiftsoglou A,
et al. Molecular analysis of ampicillin-resistant sporadic Salmonella typhi and
Salmonella paratyphi B clinical isolates. Clin Microbiol lnfect 1997;3(3):3 17-23
65. Ben Hassen A, Meddeb M, Ben Chaabane T, Zribi M, Ben Redjeb S.
Characteristics of the antibiotic resistance plasmid in Salmonella typhi isolated in
Tunis in 1990. Ann Biol Clin (Paris) 1994;52(2): 133-6
66. Shanahan PM, Karamat KA, Thomson CJ, Amyes SG. Characterization of multi-
drug resistant Salmonella typhi isolated from Pakistan. Epidemiol Infect
2000;124(1):9-16
67. Mirza S, Kariuki S. Mamun KZ, Beeching NJ, Hart CA. Analysis of plasmid and
chromosomal DNA of multidmg-resistant Salmonella enterica semvar typhi from
Asia. J Clin Microbiol2000;38(4): 1449-52
68. Ling JM, Lo NW, Ho YM, Karn KM, Hoa NT, Phi LT, et al. Molecular methods
for the epidemiological typing of Salmonella enterica serotype Typhi from Hong
Kong and Vietnam. J Clin Microbiol 2000;38(1):292-300
69. Shanahan PM. Jesudawn MV, Thomson CJ, Amyes SG. Molecular analysis of
and identification of antibiotic resistance genes in clinical isolates of Salmonella
typhi from India. J Clin Micmbiol 1998;36(6): 1595-600
70. Thong KL. Bhuna 2.4. Pang T. Multidmg-resistant strains of Salmonella enterica
wrotype typhi are genetically homogenous and coexist with antibiotic-sensitive
rtrains as distinct, independent clones. Int J Infect Dis 2000:4(4): 194-7
71. Lee K, Yong D, Yum JH. Lim YS, Kim HS, Lee BK. et al. Emergence of
multidrug-resistant Salmonella enterica serovar typhi in Korea. Antimicrob
Agents Chemother 2004;48( 1 1):4 130-5
72. Goldstein FW, Chumpitaz JC, Guevara JM, Papadopoulou B, Acar JF, Vieu JF.
Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J lnfect
Dis 1986;153(2):261-6
73. Ackers MI., Puhr ND, Tauxe RV, Mintz ED. Laboratory-based surveillance of
Salmonella serotypt mhi infections in the United States: antimicrobial
resistance on the rise. JAMA 2000;283(20):2668-73
References
74. Threlfall U, Skinner JA, Ward LR. Detection of decreased in vitro susceptibility
to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A. J
Antimicrob Chemother 200 1 ;48(5):740- 1
75. Coovadia YM, Gathiram V, Bhamjee A, Garratt RM, Mlisana K, Pillay N, et al.
An outbreak of multiresistant Salmonella typhi in South Africa. Q J Med
1992;82(298):91- 100
76, Mills-Robertson F. Addy ME, Mensah P. Crupper SS. Molecular characterization
of antibiotic resistance in clinical Salmonella typhi isolated in Ghana. FEMS
Microbiol Lett 2002;2 15(2):249-53
77. Kariuki S. Gilks C, Revathi G. Hart CA. Genotypic analysis of multidrug-
resistant Salmonella enterica serovar typhi, Kenya. Emerg Infect Dis
2000;6(6):649-5 1
78. Mermin JH, Villar R, Carpenter J. Roberts L, Samaridden A, Gasanova L, et al. A
massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated
with consumption of municipal water. J Infect Dis 1999;179(6):1416-22
79. Guha S, Jalan BY, Dey S, h o w JM, Wilson G. Shivananda PG. Salmonella
bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J
2005;7(1):23-5
XO. Mamun KZ, Tabassum S. Ashna SM, Hart CA. Molecular analysis of multi-drug
resistant -Salmonella typhi from urban paediatric population of Bangladesh.
Bangladesh Med Res Counc Bull ?004;30(3):81-6
8 1 . Le TA, Lejay-Collin M. Grimon1 PA. Hoang TL, Nguyen TV, Grimont F, et al.
Endemic, epidemic clone of Salmonella enterica serovar typhi harboring a single
multidnrg-resistant placmid i n Vietnam between 1995 and 2002. J Clin Microbiol
2004;42(7):3094-9
82. Phipps M. Pang T, Koh CL. Puthucheary S. Plasrnid incidence rate and
conjugative chloram~cnicol and tetracycline resistance plasmids in Malaysian
isolates of Salmonella typhi. Microbiol lmmunol 1991;35(2):157-61
83. Malik AS. Complications of bacteriologically confirmed typhoid fever in
children. J Trop Pediatr 2002;48(2): 102-8
viii
References
84. Tjaniadi P, Lesmana M, Subekti D. Machpud N, Komalarini S, Santoso W, et al.
Antimicrobial resistance of bacterial pathogens associated with diarrheal patients
in Indonesia. Am J Trop Med Hyg 2003;68(6):666-70
85. Pillai PK, Prakash K. Current status of drug resistance & phage types of
Salmonella typhi in India. Indian J Med Res 1993;97:154-8
86. Kamili MA, Ali G. Shah MY, Rashid S, Khan S, Allaqaband GQ. Multiple drug
resistant typhoid fever outbreak in Kashmir Valley. Indian I Med Sci 1993; 47
(6): 147-5 1
87. Sabhenval U, Chdudhary U, Saini S. Multidrug-resistant Salmonella typhi in
Haryana in 1989-90. Indian J Med Res 1992;95: 12-3
88, Sharma A, Gathwala G. Clinical profile and outcome in enteric fever, Indian
Pediatr 1993;30( 1 ):47-50
89. Rabhakar H, Kaur H, Lal M. Prevalence of multi-drug resistant Salmonella typhi
in Ludhiann Punjab.lndian J Med Sci 1996;50(8):277-9
90. Dar L. Gupta BL. Rattan A. Bhujwala RA, Shtiniwas. Multidrug resistant
Salmonella typhi in Delhi. Indian J Pediatr 1992;59(2):221-4
91. Halder KK. Dalal BS, Ghose E, Smyal S. Chloramphenicol resistant Salmonella
typhi: the cause of recent out-break of enteric fever in Calcutta. Indian J Pathol
Microbiol 1992;35( 1 ): 1 1-7
92. K m a k e r S. Biswas D. Shaikh NM, Chatterjee SK, Kataria VK. Kumar K. Role
of a large plasmid of Salmonella typhi encoding multiple drug resistance. J Med
Microbiol 199 1;34(3): 149-5 1
93. Talawadekar NN, Vadher PJ, Antani DU. Kale VV. Kamat SA.Chloramphenicol
resistant Salmonella species isolated between 1978 and 1987. J Postgrd Med
1989;35(2):79-82
94. Sheorey HS. Kaundinya DV. Hulyalkar VS, Deshpande AK. Multi drug resistant
Salmonella typhi in Bombay, lndian J Pathol Microbiol 1993;36( 1):8- 12
95. Rodrigues C. Mehta A, Mehtar S. Blackmore PH, Hakimiym A, Fazalbhoy N, et
al. Chloramphenicol resistance in Salmonella typhi. Report from Bombay. J
Assoc Physicians India 1992;40(11):729-32
References
96. Sanghavi SK, Mane MP, Niphadkar KB. Multidrug resistance in Salmonella
serotypes. Indian J Med Microbial l999;17 (2):88-90
97. Bhat KG, Andrade AT, Karadesai SG, Hemashettar BM, Patil CS. Antimicrobial
susceptibility of Salmonella typhi to quinolones & cephalosporins. Indian J Med
Res 1998; 107:247-5 1
98. Sridhar H, Macaden R, Lakshmi Devi MC, Bhat P.Chloramphenicol resistant
Salmonella typhi in Bangalore. Ind J Med Res 1983;78:3 14-1 8.
99. Jesudacon MV, John TJ. Plasmid mediated multidrug resistance in Salmonella
typhi. Indian J Med Res 1992;95:66-7.
100. Rao PS. Rajashekar V. Varghese GK, Shivananda PG. Emergence of multidrug-
resistant Salmonella typhi in rural southern India. Am J Trop Med Hyg
1093;48(1): 108-1 1
101. Rathish KC. Chandrashekar MR, Nagesha CN. Mullidrug resistant Salmonella
typhi in Bangalore. south India. Indian J Med Sci 1994;48(4):85-8
102. Sankaran K, Parvathavarthini S, Balasubramanian R. Ganesan TS, Natarajan
MK.Typhoid fever caused by chloramphenicol-resistant organisms in
Pondicherry. J Assoc Physicians India 1982;30(4):233
103. Rao RS, Amarnath SK, Sujrtha S. An outbreak of typhoid due to multidrug
resistant Salmonella typhi in Pondicherry. Trans R Soc Trop Med Hyg
lCW2;86(2):204-5
IM. Harish BN. Rashanth K. Multidrug resistant Salmonella typhi with special
reference to invitro activity of ciprofloxacin. Biomedicine 1998;18(2):62-6
105. Libeni A, Loiacono L. Ciprofloxacin versus chloramphenicol in the treatment
of salmonella infection.Int J Antimicroh Agents 2000;16(3):347-8
106. Pany CM. The treatment of multidrug-resistant and nalidixic acid-resistant
lyphoid fever in Vier Nam. Trans R SCC Trop Med Hyg 2004;98(7):413-22
107. Ruiz 1. Mechanisms of resistance to quinolones: target alterations, decreased
accumulation and DNA gyrase protection.1 Antimicrob Chemother
2003;51(5):1 109-17.
108. Hawkey PM. Mechanisms of quinolone action and microbial response. J
Antimicrob Chemother 20033 1 Suppl 1 :29-35
References
109. Horowitz DS, Wang JC. Mapping the active site tyrosine of Escherichia coli
DNA gyrase. J Biol Chem 1987;262(11):5339-44
110. Shen LL, Kohlbrenner WE, Weigl D, Baranowski J. Mechanism of quinolone
inhibition of DNA gyrase. Appearance of unique nortloxacin binding sites in
enzyme-DNA complexes. J Biol Chem 1989;264(5):2973-8
1 11. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the Cquinolones.
Microbiol Mol Biol Rev 1997;6 1 (3):377-92
112. Sonstein SA. Burnham JC. Effect of low concentrations of quinolone antibiotics
on bacterial virulence mechanisms. Diagn Microbiol Infect Dis 1983;16:277-89
113. Michel-Briand Y, Uccelli V, Lapone JM, Plesiat P. Elimination of plasmids
from Enterobacteriaceae by 4-quinolone derivatives. J Antimicrob Chemother
1986; 18(6):667-74
114. Riesenfeld C, Everett M, Piddock W. Hall BG. Adaptive mutations produce
resistance to ciprofloxacin. Ant~microb Agents Chemother 1997;41(9):2059-60
115. Bisognano C, Vaudaux P, Rohner P. Lew DP, Hooper DC. Induction of
fibronectin-binding proteins and increased adhesion of quinolone-resistant
Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob
Agents Chemother 2MW);44(6): 1428-37
116. DuPont HL. Quinolones in Salmonella typhi infection. Drugs 1993;45 Suppl
3: l 19-24
117. Rowe B, Ward LR, Threlfall U. Ciprofloxacin and typhoid fever. Lancet 1992;
339(8795):740
118. Chandel DS, Chaudhry R. Enteric fever treatment failures: a global concern.
Emerg Infect Dis 2001;7(4):762-3
119. Dutta P, Mitra U, Dutta S, Saha MR. Dey A. Roy K, et al. Ciprofloxacin
susceptible Salmonella typhi with treatment failure. J Trop Pediatr 2001;47:252-3
120. Slinger R, Desjardins M, McCarthy AE. Ramotar K, Jessamine P, Guibord C,
Toye B. Suboptimal clinical response to ciprofloxacin in patients with enkric
fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case
series. BMC Infect Dis 2004;4:36
References
121. Rupali P, Abraham OC, Jesudason MV, John TJ, Zachariah A, Sivaram S, et al.
Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella
enterica serotype Typhi. Diagn Microbiol Infect Dis 2004;49(1):1-3
122, Mandal S, Mandal MD, Pal NK. Ofloxacin minimum inhibitory concentration
versus disk diffusion zone diameter for Salmonella enterica serovar Typhi
isolates: problems in the detection of ofloxacin resistance. Jpn .I lnfect Dis
2003;56(5-6):2 10-2
123. Renuka K. Kapil A, Kabra SK, Wig N, Das BK, Prasad VV, et al. Reduced
susceptibility to ciprofloxacin and gyta gene mutation in North Indian strains of
Salmonella enterica serotype Typhi and serotype Pwatyphi A. Microb Drug
Resist 2004; lO(2): 146-53
124. Kadhiravan T. Wig N. Kapil A, Kabra SK, Renuka K, Misra A. Clinical
outcomes in typhoid fever: adverse impact of infection with nalidixic acid-
resistant Salmonella typhi. BMC lnfect Dis 2005;5(1):37
125. Crump JA, Barrett TJ, Nelson IT, Angulo FJ. Reevaluating fluoroquinolone
breakpoints for Salmonella enterica serotype Typhi and for non-Typhi
salmonellae. Clin lnfect Dis 2003;37(1):75-81
126. Allen KJ, Poppe C. Phenotypic and genotypic characterization of food animal
isolates of Salmonella with reduced sensitivity to ciprofloxacin. Microb Drug
Resist 2002;8(4):375-83
127. Hakanen A. Kotilainen P, Jalava J, Siitonen A, Huovinen P. Detection of
decreased fluoroquinolone susceptibility in Salmonellas and validation of
nalidixic acid screening test. 1 Clin Microbiol 1999;37(11):3572-7
128. Oliveira CJ, Carvalho LF, Fernandes SA, Tavechio AT. Menezes CC,
Domingues FJ Jr. Antimicrobial resistance of Salmonella serotypes isolated from
slaughter-age pigs and environmental samples. Microb Drug Resist
2002;8(4):407- 1 1
129. Moniot-Ville N, Guiberl J, Moreau N, Acat JF, Collatz E, Gutmann L.
Mechanisms of quinolone resistance in a clinical isolak of Escherichia coli highly
resistant to fluoroquinolones but susceptible to nalidixic acid. Antimicrob Agents
Chcmother 199 1 ;35(3):5 19-23
xii
References
130, Cambau E. Bordon F, Collatz E, Gutmann L. Novel gyrA point mutation in a
strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.
Antimicrob Agents Chemother 1993;37(6): 1247-52
131, Kapil A, Renuka K, Das B. Nalidixic acid susceptibility test to screen
ciprofloxacin resistance in Salmonella typhi. Indian J Med Res 2002;115:49-54
132. Ling JM. Zhou GM, Woo TH, French GL.Antimicrobial susceptibilities and
beta-lactamase production of Hong Kong isolates of gastrwnteric salmonellae
and Salmonella 1yphi.J Antimicrob Chemother 1991;28(6):877-85
13.1. Threlfall E. Ward L. Skinner J , Smith H, Lacey S. Ciprofloxacin-resistant
Salmonella typhi and treatment failure. Lancet 1999;353: 1590-1
134. Threlfall EJ, Graham A, Cheaqty T, Ward LR, Rowe B. Resistance to
ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996. J
Clin Pathol 1997;50( 12): 1027-8
135. Caumes E. Ehya N. Nguyen J, Bricaire F.Typhoid and pwatyphoid fever: a 10-
year retrospective study of 41 cases in a Parisian hospital. J Travel Med
2001 ;8(6):293-7
136. Hakanen A, Kotilainen P, Huovinen P, Helenius H, Siitonen A. Reduced
tluoroquinolone susceptibility in Salmonella enterica serotypes in travelers
returning from Southeast Asia. Emerg Infect Dis 2001 ;7(6):996-1003
137 Threlfirll €3. Fisher IS. Berghold C. Gerner-Smidt P, Tschape H, Cormican M,
et nl. Antimicrobial drug resistance in isolates of Salmonella enterica from cases
of salmonellosis in humans in Europe in 2000: results of international multi-
centre surveillance. Euro Surveil1 2003;8(2):41-5
138. Ktviuki S. Revathi G, Muyodi 1. Mwituria J . Munyalo A, Mina S, et al.
Characterization of multidrug-resistant typhoid outbreaks in Kenya. J Clin
Microbiol 200442(4): 1477-82
139. Wain J . Hoa NT. Chinh NT, Vinh H, Everett MJ. Diep TS, et al. Quinolone-
tesistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical
response to treatment. Clin Infect Dis 1997;25(6): 1404-1 0
140. Parry C, Wain J, Chinh N, Vinh H, Farrar J . Quinolone-resistant Salmonella
typhi in Vietnam Lancet 1998;351: 1289
xiii
141. Asna SM, Haq JA, Rahman MM. Nalidixic acid-resistant Salmonella enterica
serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment
failure: a report from Bangladesh. Jpn J Infect Dis 2003;56(1):32-3.
142. Murdoch DR, Woods CW, Zimmerman MD, Dull PM, Belbase RH, Keenan kl,
et al. The etiology of febrile illness in adults presenting to Patan hospital in
Kathmandu. Nepal. Am J Trop Med Hyg 2004;70(6):670-5
143. Shwe TN, Nyein MM, Yi W, Mon A. Blood culture isolates from children
admitted to Medical Unit 111. Yangon Children's Hospital, 1998. Southeast Asian
J Trop Med Public Health 2002;33(4):764-71
144. Hirose K, Tamura K, Sagara H, Watanabe H. Antibiotic susceptibilities of
Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated
from patients in Japan. Antimicrob Agents Chemorher 2001;45(3):956-8
145. Biswal N, Mathai B, Bhatia BD, Srinivasan S, Nalini P. Enteric fever: a
changing perspective. Indian Pediatr 1994;3 1 (7):813-9
1.16. Nath G, Tikoo A. Manocha H, Tripathi AK, Gulati AK. Drug resistance in
Salmonella typhi in north India with special reference to ciprofloxacin. J
Antimicrob Chemother 2000;46(1): 149-50
117. Jesudason MV. Mnlathy B, John TI. Trend of increasing levels of minimum
inhibitory concentration of ciprofloxacin to Salmonella typhi. Indian J Med Res
1096; 1033247-9
118. Rathish KC. Chandrashekar MR. Nagesha CN. An outbreak of rnultidrug
resistant typhoid fever in Bangalore. Indian J Pediatr 1995;62(4):445-8
119. Brown JC, Shanahan PM, Jesudason MV, Thomson CJ, Amyes SG. Mutations
responsible for reduced susceptibility to 4quinolones in clinical isolates of multi-
resistant Salmonella typhi in India. J Antimicrob Chemother 1996;37(5):891-900
150. Kumar R. Aneja KR. Roy P, Sharma M. Gupta R, Ram S. Evaluation of
minimum inhibitory concentration of quinolones and third generation
oephalosporins to Salmonella typhi isolates, Indian J Med Sci 2002;56(1): 1-8
151. Rodrigues C, Mehta A, Joshi VR. Nalidixic acid-resistant Salmonella t p h i in
Mumbai. Natl Med J India 1999;12(2):88
xiv
References
152. Saha MR, Dutta P, Niyogi SK, Dutta S. Mitra U, Ramamurthy T, et al.
Decreasing trend in the occurrence of Salmonella enterica serotype Typhi
amongst hospitalised children in Kolkata, India during 1990-2000. Indian J Med
Res 2002; 1 15:46-8
153. Walia M, Gaind R, Mehta R, Paul P. Aggarwal P, Kalaivani M. Current
perspectives of enteric fever: a hospital-based study from India. Ann Trop
Paediatr 2005;25(3): 161 -74
154. Mohanty S, Renuka K, Sood S, Dm BK, Kapil A. Antibiogram pattern and
seasonality of Salmonella serotypes in a North Indian tertiary care hospital.
Epidemiol Infect 2006: 14: 1-6
155. Mehta G, Randhawa VS, Mohapatra NP. Intermediate susceptibility to
ciprofloxacin in Salmonella typhi strains in India. Eur J Clin Microbiol Infect Dis
2001;20(10):760-1
156. Joshi S, Wattal C, JK Oberoi, KJ Rasad. Quinolones-drug of choice for enteric
fever? Indian J Med Microbiol 2004;22(4): 27 1-2
157. Sun L. Sreedharan S, Plummer K, Fisher LM. NorA plasmid resistance to
fluoroquinolones: role of copy number and norA frameshift mutations.
Antimicrob Agents Chemother 1996;40(7): 1665-9
1%. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect
Dis 2001;7(2):337-41
1.59. Yoshida H, Bogaki M, Nakarnura M, Nakarnum S. Quinolone resistance-
determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob
Agents Chemother 1990;34(6): 127 1-2
160. Goni-Umza M, Arpin C. Capdepuy M, Dubois V, Caumette P, Quentin C.
Type I1 topoisomerase quinolone resistance-determining regions of Aerornonas
caviae. A. hydrophila, and A. sobria complexes and mutations associated with
quinolone mistance. Antimicrob Agents Chemother 2002;46(2):350-9
161. Waters B. Davies J. Amino acid variation in the GyrA subunit of bacteria
potentially associated with natural resistance to fluoroquinolone antibiotics.
Antimicrob Agents Chemother 1997;4 1 ( 12):2766-9
References
162. Weigel LM, Steward CD, Tenover FC. gyrA mutations associated with
fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob
Agents Chernother 1998;42(10):2661-7
163. Bagel S, Hullen V. Wiedemann 9, Heisig P, Impact of gyrA and parC mutations
on quinolone resistance, doubling time, and supercoiling degree of Escherichia
coli. Antimicrob Agents Chemother 1999;43(4):868-75
164. Higgins ffi, Ruit AC, Milatovic D, Verhoef J, Schmitz FJ. Mutations in GyrA,
Pa&, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. Int J
Antimicrob Agents 2003;21(5):409- 13
165. Saenz Y, Zdrazaga M. Brinas L, Ruiz-Lama F, Torres C. Mutations in gyrA
and par€ genes in nalidixic acid-resistant Escherichia coli strains from food
products, humans and animals. J Antimicrob Chemother 2003;5 l(4): 1001 -5
166. Akasaka T. Tanaka M, Yamaguchi A, Sato K. Type I1 topoisomerase mutations
in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in
1998 and 1999: role of target enzyme in mechanism of fluoroquinolone
resistance. Antimicrob Agents Chemother 2001;45(8):2263-8
167. Navia MM. Ruiz J, Ribera A, de Anta MT, Vila J. Analysis of the mechanisms
of quinolone resistance in clinical isolates of Citrobacter freundii. J Antimicrob
Chemother 1999;44(6):743-8
168. Vila J. Ruiz J, Marco F, Barcelo A. Goni P, Giralt E, et al. Association between
double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of
Escherichia coli and MICs. Antimicrob Agents Chemother 1994;38(10):2477-9
169. Everett UI, Jin YF, Ricci V, Piddock U. Contributions of individual
mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated
from humans and animals. Antimicrob Agents Chemother 1996;40( 10):2380-6
170. Liebana E, Clouting C. Cassar CA, Randall LP, Walker RA, Threlfall U, et al.
Comparison of gyrA mutations, cyclohexane resistance, and the presence of class
I integrons in Salmonella enterica from farm animals in England and Wales. J
Clin Microbial 2002;40(4): 148 1-6
17 1 . Giraud E, Brisabois A, Martel JL. Chaslus-Dancla E. Comparative studies of
mutations in animal isolates and experimental in vitro- and in vivo-selected
References
mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-
resistant strains in the field. Antimicrob Agents Chemother 1999;43(9):2131-7
172. Eaves DJ. Randall L, Gray DT, Buckley A, Woodward UI, White AP, et al.
Prevalence of mutations within the quinolone resistance-determining region of
gyrA, gyrB, p a s , and parE and association with antibiotic resistance in
quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother
2004;48(10):4012-5
173. Soto SM, Gonzalez-Hevia MA, Mendoza MC. Antimicrobial resistance in
clinical isolates of Salmonella enterica serotype Enteritidis: relationships between
mutations conferring quinolone resistance, integrons, plasmids and genetic types.
J Antimicrob Chemother 2003;5 l(5): 1287-9 1
174. Chu C, Su LH, Chu CH, Baucheron S, Cloeckaen A, Chiu CH. Resistance to
fluoroquinolones linked to gyrA and par C mutations and overexpression of acr
AB efflux pump in Salmonella enterica serotype Choleraesuis. Microb Drug
Resist 2005; 11(3):248-53
175. Ruiz J, Castm D, Goni P, Santamaria JA. Bonego JJ. Vila J. Analysis of the
mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of
Salmonella serotype Typhimurium. J Med Microbiol 1997;46(7):623-8
176. Ling JM, Chan EW, Lam AW, Cheng AF. Mutations in topoisomerase genes of
fluoroquinolone-resismt s;llmonellae in Hong Kong. Antimicrob Agents
Chemother 2003:47(11):3567-73
177. Griggs DJ, Gensberg K, Piddock U. Mutations in gyrA gene of quinolone-
resistant Salmonella serotypes isolated from humans and animals. Antimicrob
Agents Chemother 1996;40(4): 1009- 13
178. Phung le V, Ryo H, Nomura T. Specific gyrA mutation at codon 83 in nalidixic
acid-resistant Salmonella enterica serovar Typhi strains isolated from Vietnamese
patients. Antimicrob Agents Chemother 2002;46(6):2052-3
179. Piddock U. Ricci V. M c b n I. Griggs DJ. Role of mutation in the gyrA and
parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals
in the United Kingdom. J Antimicrob Chemother 1998;41(6):635-41
xvii
References
180, Heisig P. Genetic evidence for a role of parC mutations in development of high-
level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents
Chemother 19%;40(4):879-85
181. Ince D, Hooper DC. Quinolone resistance due to reduced target enzyme
expression. J Bacteriol 2003;185(23):6883-92
182. Koutsolioutsou A, Martins EA, White DG, Levy SB, Demple B. A soxRS-
constitutive mutation contributing to antibiotic resistance in a clinical isolate of
Salmonella enterica (Serovar typhimurium). Antimicrob Agents Chemother
2001 ;45(1):38-43
183. Putman M, van Veen HW, Konings WN. Molecular properties of bacterial
multidrug transporters. Microbiol Mol Biol Rev 2000;64(4):672-93
184. Randall LP, Woodward MJ. Multiple antibiotic resistance (mar) locus in
Salmonella enterica serovar typhimurium DT104. Appl Environ Microbiol
200 1 ;67(3): 1 190-7
185. Sulavik MC, Dazer M. Miller PF. The Salmonella typhimurium mar locus:
molecular and genetic analyses and assessment of its role in virulence. J Bacteriol
1997; 179(6): 1857-66
186. Grkovic S, Brown MH, Skumy RA. Regulation of bacterial drug export
systems. Microbiol Mol Biol Rev 2002;66(4):671-701
187. Alekshun MN, Levy SB. Regulation of chrornosornally mediated multiple
antibiotic resistance: the mar regulon. Antimicrob Agents Chemother
1997;41(10):2067-75
188. Alekshun MN. Kim YS, Levy SB. Mutational analysis of MarR, the negative
regulator of marRAB expression in Escherichia coli, suggests the presence of two
regions required for DNA binding. Mcl Microbiol 2000,35(6):1394-404
189. Alehhun MN, Levy SB. The mar regulon: multiple resistance to antibiotics and
other toxic chemicals. Trends Microbiol 1999;7(10):410-3
190. Martin RG, Jair KW. Wolf RE Jr, Rosner JL. Autoactivation of the marRAB
multiple antibiotic resistance operon by the MarA tmscriptional activator in
Escherichia coli. J Bacteriol 19%; 178(8):22 16-23
xviii
References
191. Barbosa TM, Levy SB. Differential expression of over 60 chromosomal genes
in Escherichia coli by constitutive expression of MarA. J Bacteriol
2000; t82( 12):3467-74
192. Cohen SP. Hachler H, Levy SB. Genetic and functional analysis of the multiple
antibiotic resistance (mar) locus in Escherichia coli. J Bacteriol
1993; 175(5): 1484-92
193. Alekshun MN, Levy SB. Alteration of the repressor activity of MarR, the
negative regulator of the Escherichia coli marRAB locus, by multiple chemicals
in vitro. J Bacteriol 1999; 181(15):4669-72
194. Bina X. Perreten V. Levy SB. The periplasmic protein MppA requires an
additional mutated locus to repress marA expression in Escherichia coli. J
Bacteriol 2003; 185(4): 1465-9
195. Chollet R, Bollet C, Chevalier J, Mallea M, Pages JM, Davin-Regli A, mar
Operon involved in multidrug resistance of Enterobacter aerogenes. Antimicrob
Agents Chemother 2002:46(4): 1093-7
196. Goldman JD, White DG, Levy SB. Multiple antibiotic resistance (mar) locus
protects Escherichia coli from rapid cell killing by fluoroquinolones. Antiminob
Agents Chemother 1996;40(5): 1266-9
197. Oethinger M. Kern WV, Jellen-Rimer AS, McMurry LM, Levy SB.
Ineffectiveness of topoisomerase mutations in mediating clinically significant
fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux
pump. Antimicrob Agents Chemother 2000;44(1):10-3
198. Oethinger M. Podglajen I, Kern WV, Levy SB. Overexpression of the marA or
soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.
Andmicrob Agents Chemother 1998;42(8):2089-94
199. Cohen SP, McMurry LM, Hooper DC, Wolfson JS, Levy SB. Cross-resistance
to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected
by tetracycline or chloramphenicol: decreased dmg accumulation associated with
membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother
1989;33(8): 13 18-25
xix
References
200. Linde HJ, Notka F. Metz M, Kochanowski B, Heisig P, Lehn N. In vivo
increase in resistance to ciprofloxacin in Escherichia coli associated with deletion
of the C-terminal part of MarR. Antimimob Agents Chemother 2000;44(7): 1865-
8
201, Maneewannakul K, Levy SB. Identification for mar mutants among quinolone-
resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother
1996;40(7): 1695-8
202. Moken MC. McMurry LM, Levy SB. Selection of multiple-antibiotic-resistant
(mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the
mar and acrAB loci. Antimicrob Agents Chemother 1997;41(12):2770-2
203. Oethinger M. Kern WV. Goldman JD, Levy SB. Association of organic solvent
tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli. J
Antimicrob Chemother 1998;41(1): 11 1-4
2 0 4 Park YH, Yoo JH, Huh DH, Cho YK, Choi JH, Shin WS. Molecular analysis of
fluoroquinolone-resistance in Escherichia coli on the aspect of gyrase and
multiple antibiotic resistance (mar) genes. Yonsei Med J 1998;39(6):534-40
205. Bryskier A. Fluoroquinolones: Mechanisms of action and resistance. Int J
Antimicrob Agent 1993;2:151-84
206. Piddock U. Jin YF. Ricci V. Asuquo AE. Quinolone accumulation by
Pseudomonas aemginosa, Staphylococcus aureus and Escherichia coli. J
Antimicrob Chemother 1999;43( 1 ):61-70
207. Jalal S. Ciofu 0, Hoiby N, Gotoh N, Wretlind B. Molecular mechanisms of
fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic
fibrosis patients. Antimicrob Agents Chemother 2000,44(3):710-2
?OR. White DG. Goldman JD, Demple B, Levy SB. Role of the acrAB locus in
organic solvent tolerance mediated by expression of marA, soxS, or robA in
Escherichia coli. J Bacleriol 1997; 179(19):6122-6
209. Mazzatiol A. Tokue Y. Kanegawa TM. Comaglia G, Nikaido H. High-level
fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce
multidmg efflux protein AcrA. Antimicrob Agents Chemother 2000;44(12):3441-
3
References
210. Cohen SP, Hooper DC, Wolfson JS, Souza KS, McMurry LM, LVY SB.
Endogenous active efflux of noffloxacin in susceptible Escherichia coli.
Antimicrob Agents Chemother 1988;32(8): 1 1 87-91
21 1. Levy SB. Active efflux mechanisms for antimicrobial resistance. Antimicrob
Agents Chemother 1992;36(4):695-703
212. Yu J L Grinius L, Hooper DC. NorA functions as a multidnrg efflux protein in
both cytoplasmic membrane vesicles and reconstituted proteoliposomes. J
Bacteriol 2002; 184(5): 1370-7
213. Giraud E. Cloeckaen A, Kerboeuf D, Chaslus-Dancla E. Evidence for active
efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella
enterica serovar typhimurium. Antimicrob Agents Chemother 2000;44(5): 1223-8
214. Piddock U, White DG, Gensberg K, Pumbwe L, Griggs DJ. Evidence for an
efflux pump mediating multiple antibiotic resistance in Salmonella enterica
serovar Typhimurium. Antimicrob Agents Chemother 2000;44(11):3118-21
215. Baucheron S. Imberechts H, Chaslus-Dancla E, Cloeckaert A. The AcrB
multidrug transporter plays a major role in high-level fluoroquinolone resistance
in Salmonella enterica serovar typhimurium phage type DT204. Microb Drug
Resist 2002;8(4):28 1-9
2 16. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited.
Mlcrobiol Mol Biol Rev 2003;67(4):593-656
217. Nikaido H, Vaara M. Molecular basis of bacterial outer membrane
permeability. Micmbiol Rev 1985;49(1):1-32
218. Nikaido H, Nikaido K, Haraynma S. Identification and characterization of
porins in Pseudomonas aeruginosa. J Biol Chem 199 1 ;266(2):770-9
219. Hancock RE. Role of porins in outer membrane permeability. J Bacteriol
1987; 169(3):929-33
220. Hernandez-Alles S, Benedi VJ, Martinez-Martinez L, Pascual A, Aguilar A.
Tomas JM, et al. Development of resistance during antimicrobial therapy caused
by insertion sequence interruption of porin genes. Antimicrob Agents Chemother
1999; 43(4): 937-9
References
221. Oliver A, Weigel LM, Ruheed JK, McGowan Jr JE Jr, Raney P, Tenover FC.
Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli.
Antimicrob Agents Chemother 2002;46(12):3829-36
222. Heisig P. Tschomy R. Characterization of fluoroquinolone-resistant mutants of
escherichia coli selected in vitro. Antimicrob Agents Chemother
1994;38(6): 1284-9 1
223. Nestorovich EM. Danelon C. Winterhalter M, Beznrkov SM. Designed to
penetrate: time-resolved interaclion of single antibiotic molecules with bacterial
pores. Proc Natl Acad Sci U S A 2002;99(15):9789-94
224. Zhanel GG, Karlowsky JA, Saunders MH, Davidson RJ, Hoban DJ, Hilncock
RE, et al. Development of multiple-antibiotic-resistant (Mar) mutants of
Pseudomonu aeruginosa after serial exposure to fluoroquinolones. Antimicrob
Agents Chemother 1995;39(2):489-95
225. Daikos GL. Lolms VT, Jackson GG. Alterations in outer membrane proteins of
Pseudomonas aeruginosa associated with selective resistance to quinolones.
Antimicrob Agents Chemother 1988;32(5):785-7
226. Rajyaguru JM, Muszynski MJ. Association of resistance to
trimethoprim/sulphmethoxazole, chloramphenicol and quinolones with changes
in major outer membrane proteins and iipopolysaccharide in Burkholderia
cepacia. J Antimicroh Chemother 1997;40(6):803-9
227. Piddock U, Hall MC. Walters RN. Phenotypic characterization of quinolone-
resistant mutants of Enterobactenaceae selected from wild type, gyrA type and
multiply-resistant (marA) type strains. J Antirnicrob Chemother 1991;28(2):185-
98
228. Tavio MM, Vila J. Ruiz J . Ruiz J . Martin-Sanchez AM, Jimenez de Anta MT.
Mechanisms involved in the development of resistance to fluoroquinolones in
Escherichia coli isolates. J Antimicrob Chemother 1999;44(6):735-42
229. Hirai K. Aoyama H, Suzue S, lrikura T, lyobe S, Mitsuhashi S. Isolation and
characterization of norfloxacin-resistant mutants of Escherichia coii K-12.
Antimicrob Agents Chemother 1986;30(2):248-53
References
230. Cohen SP, McMuny LM, Levy SB. marA locus causes decreased expression of
OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J
Bacterial 1988;170(12):5416-22
231. Yamaguchi Y, Tornoyasu T, Takaya A, Morioka M, Yamamoto T. Effects of
disruption of heat shock genes on susceptibility of Escherichia coli to
fluoroquinolones. BMC Microbiol 2003;3: 16
232. Hallett P, Mehltrt A, Maxwell A. Escherichia coli cells resistant to the DNA
gyrase inhibitor, ciprofloxacin, overproduce a 60 kD protein homologous to
GroEL. Mol Microbiol 1990;4(3):345-53
233. Martinez-Martinez L, Pascual A, Conejo Mdel C, Gucia I, Joyanes P,
Domenech-Sanchez A, et al. Energy-dependent accumulation of norfloxacin and
porin expression in clinical isolates of Klebsiella pneumoniae and relationship to
extended-spectrum beta-lactamoe production. Antiniicrob Agents Chemother
2(X)2;46( 12):3926-32
234. Giraud E, Cloeckacrt A, Baucheron S, Mouline C, Chaslus-Dancla E. Fitness
cost of fluoquinolone resistance in Salmonella enterica serovar Typhimurium.J
Med Microbiol 2003;52(8):697-703
235. Martinez-Martinez L Pascual A, Garcia 1, Tran J, Jacoby GA. Interaction of
plasmid and host quinolone resistance. J Antimicrob Chemother 2003;51(4): 1037-
9
236. Wang M. Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-
medialed quinolone resistance in clinical isolates of Escherichia ooli from
Shanghai, China. Antimicrob Agents Chemother 2003;47(7):2242-8
237. Kern WV, Oethinger M, Jellen-Ritter AS, Levy SB. Non-target gene mutations
in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob
Agents Chemother 2000,44(4):814-20
238. Hansen H, Heisig P. Topoisomerase IV mutations in quinolone-resistant
salmonellae selected in vim. Microb Drug Resist 2003;9(1):25-32
239. Zafar A, lbrahirn NG, Ahsan T, Abbas 2, Zaidi A, Hacan R. Nalidixic acid
screening test in detection of decreased fluoquinolone susceptibility in
References
Salmonella typhi isolated from blood. J Coil Physicians Surg Pak 2005;15(7):413-
7
240. Hirose K, Tarnura K, Watanabe H. Screening method for Salmonella enterica
serovar Typhi and serovar Paratyphi A with reduced susceptibility to
fluoroquinolones by PCR-restriction fragment length polymorphism. Microbiol
lmmunol2003;47(2): 16 1-5
241. Walker RA, Skinner JA, Ward LR, Threlfall EJ. Lightcycler gyrA mutation
assay (GAMA) identifies heterogeneity in GyrA in Salmonella enterica serotypes
Typhi and Paratyphi A with decreased susceptibility to ciprofloxacin. Int J
Antimicrob Agents 2003:22(6):622-5
242. Ames GF. Spudich' EN, Nikaido H. Rote~n composition of the outer membrane
of Salmonella typhimurium: effect of lipopolysaccharide mutations. J Bacteriol
1974; 1 17(2):406- 16
243. Chilcott GS, Hughes KT. Coupling of flagellar gene expression to flagellar
assembly in Salmonella enterica serovar typhimurium and Escherichia coli.
Microbiol Mol Biol Rev 2000;64(4):694-708
244. Huang X, Phung le V, Dejsirilert S. Tishyadhigama P, Li Y, Liu H, et al
Cloning and chamcterization of the gene encoding the 266 antigen of Salmonella
enterica serovar Typhi.FEMS Microbiol Lett 2004;234(2):239-46
245. Guinee PA. Jansen WH, M a s HM. Le Minor L. Beaud R. An unusual H
antigen (266) in strains of Salmonella typhi. Ann Microbiol (Paris)
1981;132(3):331-4
246. Dauga C, Zabrovskaia A, Grimont PA. Restriction fragment length
polymorphism analysis of some flagellin genes of Salmonella enterica. J Clin
Microbiol 1998;36(10):2835-43
247. Minamino T, Macnab RM. Components of the Salmonella flagellar export
apparatus and classification of export substrates. J Bacteriol 1999; 181(5): 1388-94
248. Wang JY, Noriega FR. Galen JE, Barry E, Levine MM. Constitutive expression
of the Vi polysaccharide capsulu antigen in attenuated Salmonella erlterica
serovar typhi oral vaccine strain CVD 909. Infect Immun 2000;68(8):4647-52
References
249. Jones CJ, Macnab RM. Flagellar assembly in Salmonella typhimurium: analysis
with temperature-sensitive mutants. J. Bacteriol 1990; 172: I 327-39
250. Hitchcock PJ, h i v e L. Makela PH, Rietschel ET, Striamatter W, Morrison E.
Lipoplysaccharide nomenclature--past, present, and future. J Bacteriol
1986; 166(3):699-705
251. Bittner M, Saldias S. Estevez C, Zaldivar M, Marolda CL, Valvano MA, 1990.
0-antigen expression in Salmonella enterica serovar Typhi is regulated by
nitrogen availability through RpN-mediated transcriptional control of the rfaH
gene. Microbiology 2002;148(Pt 12):3789-99
252. Shands JW Jr. Evidence for a bilayer structure in gram-negative
lipplysaccharide: relationship to toxicity. Infect Immun 1971;4(2):167-72
253. Munford RS. Hall C L Rick PD. Size heterogeneity of Salmonella typhimurium
lipopolysaccharides In outer membranes and culture supernatant membrane
fragments. J Bacterial 1980; 144(2):630-40
2.M. Peterson AA, McGroarty EJ. High-molecular-weight components in
lipplysaccharides of Salmonella typhimurium, Salmonella minnesota, and
Bcherichia coli. J Bacteriol 1985; 162(2):738-45
255. Chart H. Lipoplysaccharide chernotyping. In: Howard J, Whitecombe DM,
editors. Diagnostic bacteriology protocols. New Jersey, Humana Press. 1995.
p.41-8. (Methods in molecular biology -Volume 46).
256. Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella
lipplysaccharide chemotypes in silver-stained plyacrylamide gels. J Bacteriol
1983; 154( 1):269-77
257. Osborn MJ, Gander JE, Parisi E. Mechanism of assembly of the outer
membrane of Salmonella typhimurium. Site of synthesis of lipopolysaccharide. J
Biol Chem 1972 ;247(12):3973-86
258. Yeh HY. Jacobs DM. Characterization of lipopolysaccharide fractions and their
interactions with cells and model membranes. J Bacteriol 1992;174(1):336-41
259. Batchelor RA, Alifano P. Biffali E, Hull SI, Hull RA. Nucleotide sequences of
the genes regulating 0-polysaccharide antigen chain length (rol) from Escherichia
References
coli and Salmonella typhimurium: protein homology and functional
complementation. J. Bacteriol 1992;174:5228- 36.
260. Rojas G, Saldias S, Bittner M. Zaldivar M, Contreras I. The rfaH gene, which
affects lipopolysaccharide synthesis in Salmonella enterica serovar Typhi, is
differentially expressed during the bacterial growth phase. FEMS Microbiol Lett
2001 ;204(1): 123-8
261. Calderon I, Lobes SR, Rojas HA, Palomino C, Rodriguez LH, Mora
GC.Antibodies to porin antigens of Salmonella typhi induced during typhoid
infection in humans. Infect Immun 1986;52(1):209-12
262. Muthukkumar S, Muthukkaruppan VR. Detection of porin antigen in serum for
early diagnosis of mouse infections with Salmonella typhimurium. FEMS
Microbiol lmmunol 1992:4(3):147-53
263. Simonet V, Mallea M, Fourel D, Bolla JM, Pages JM. Crucial domains are
conserved in Enterobacteriaceae porins. FEMS Microbiol Lett 1996;136(1):9 1-7
264. Faundez G, Aron L. Cabello FC. Chromosomal DNA, iron-transport systems,
outer membrane proteins, and enterotoxin (heat labile) production in Salmonella
typhi strains. J Clin Microbiol 1990;28(5):894-7
26.5. Puente JL, Rores V, Fernandez M, Fuchs Y, Calva E. isolation of an ompC-like
outer membrane protein gene from Salmonella typhi. Gene 1987:6 I( 1 ):75-83
266. Rocque WJ, Coughlin RT, McGroMy W. Lipopolysaccharide tightly bound to
porin monomers ;md trimers from Escherichia coli K-12. J Bacteriol
1987; 169(9):4003- 10
267. Arcidiacono S. Butler MM, Mello CM. A rapid selective extraction procedure
for the outer membrane protein (OmpF) from Escherichia coli. Protein Expr Purif
2002;25( I): 134-7
268. C o n m m I, Munoz L, Toro CS, Mora GC. Heterologous expression of
Escherichia coli porin genes in Salmonella typhi Ty2: regulation by medium
osmolarity, temperature and oxygen availability. FEMS Microbiol Lett
1995;133(1-2): 105-1 1
269. Saint N, Dc E, Julien S, Orange N, Molle G, Ionophore properties of OmpA of
Escherichia coli. Biochim Biophys Acta 1993;1145(1):119-23
References
270. Santiviago CA, Tor0 CS, Bucarey SA, Mora GC. A chromosomal region
surrounding the ompD porin gene marks a genetic difference between Salmonella
typhi and the majority of Salmonella serovars. Microbiology 2001;147(7):1897-
907
271. Molloy MP, Herbert BR. Slade MB, Rabilloud T, Nouwens AS, Williams KL,
et al. Rotaomic analysis of the Escherichia coli outer membrane. Eur J Biochem
2000;267(10):2871-81
272. Zugel U, Kaufmann SH. Role of heat shock proteins in protection from and
pathogenesis of infectious diseases. Clin Microbiol Rev 1999; 12(1):19-39
273. Findlay JBC. Structure and function in membrane transport systems. Curr Opin
Struct Biol 199 1 ; 1(5): 1804- 10
274. Nikaido H. Pwins and specific diffusion channels in bacterial outer membranes.
J Biol Chem 1994;269(6):3905-8
275. Klebba PE, Newton SM. Mechanisms of solute transport through outer
membme porins: burning down the house. Curr Opin Microbiol 1998;1(2):238-
47
276. Achouak W, Heulin T, Pages JM. Multiple facets of bacterial porins. FEMS
Microbiol Lett 2001 ; 199( 1 ): 1-7
277. Liu X, Ferenci T. Regulation of porin-mediated outer membrane permeability
by nutrient limitation in Escherichia coli. J Bacterial 1998; 180(15):39 17-22
278. Bernstein HD. The biogenesis and assembly of bacterial membrane proteins.
Curr Opin Microbiol 2000;3(2):203-9
279. Danvin KH, Miller VL. Molecular basis of the interaction of Salmonella with
the intestinal mucosa. Clin Microbiol Rev 1999; 12(3):405-28
280. House D, Bishop A, Pany C, Dougan G, Wain J. Typhoid fever: pathogenesis
and disease. Curr Opin Infect Dis 200 1 ; 14 (5): 567-72
281. Levine MM, Tacket CO, Sztein MB. Host-Salmonella interaction: human trials.
Microbes Infect 2001 ;3(14-15): 1271-9
282. Wain J. Diep TS, Ho VA, Walsh AM, Nguyen 'IT, Parry CM, et al.
Quantitation of bacteria in blood of typhoid fever patients and relationship
References
between counts and clinical features, transmissibility, and antibiotic resistance. J
Clin Microbiol 1998:36(6): 1683-7
283. G o t u m E, Morris JG Jr, Benavente L, Wood PK, Levine 0, Black RE, et al.
Association between specific plasmids and relapse in typhoid fever. J Clin
Microbiol 1987;25(9): 1779-81
284. Carter PB, Collins FM. The route of enteric infection in normal mice. J Exp
Med 1974; 139(5): 1 189-203
285. Mastroeni P. Menager N. Development of acquired immunity to Salmonella. J
Med Microbiol 2003;52(6):453-9
286. Pascopella L, Raupach B. Ghori N, Monack D, Falkow S, Small PL. Host
restriction phenotypes of Salmonella typhi and Salmonella gallinarum. Infect
lmmun 1995;63(1 1 ):4329-35
287. Zhang XL, Tsui IS. Yip CM. Fung AW, Wong DK, Dai X, et al. Salmonella
enterica serovar typhi uses type IVB pili to enter human intestinal epithelial cells.
Infect lmmun 2000;68(6):3067-73
288. Weinstein DL. O'Neill BL, Hone DM, Metcalf ES. Differential early
interactions between Salmonella enterica serovar Typhi and two other pathogenic
Salmonella serovan with intestinal epithelial cells. Infect lmmun
I W8;66(5):23 10-8
289. Finlay BB, Fillkaw S. Common themes in microbial pathogenicity revisited.
Microbiol Mol Biol Rev 1997;61(2): 136-69
290. Monack DM. Raupach B. Hromockyj AE. Falkow S. Salmonella typhimurium
invasion induces apoptosis in infected macrophages. Roc Natl Acad Sci U S A
1996;93( 18):9833-8
291. Monack DM, Hersh D. Ghori N, Bouley D, Zychlinsky A, Falkow S.
Salmonella exploits caspase-l to colonize Peyer's patches in a murine typhoid
model. J Exp Med 2000,192(2):249-58
292. Finlay BB, Brumell JH. Salmonella interactions with host cells: in vitro to in
vivo. Philos Trans R Soc Lond B Biol Sci 2MM;355(1397):623-31
293. Wain 1. House D, Pukhill J. Parry C, Dougan G. Unlocking the genome of the
human typhoid bacillus.Lancet Infect Dis 2002;2(3): 163-70
xxviii
References
294. Paesold G, Guiney DG, Eckmann L, Kagnoff MF. Genes in the Salmonella
~athogenicity island 2 and the Salmonella virulence plasmid are essential for
Salmonella-induced apoptosis in intestinal epithelial cells. Cell Microbiol
2002;4(11):771-81
295. Chakravortty D, Hansen-Wester I, Hensel M. Salmonella pathogenicity island 2
mediates protection of intracellular Salmonella from reactive nitrogen
intermediates. J Exp Med 2002; 195(9): 1 155-66
296. Lee TP, Hoffman SL. Typhoid fever. In: Guerrant RL, Walker DH, Weller PF.
Tropical infectious disease- principles pathogens and practice. Philadelphia;
Churchill Livingstone: 1999. p. 277-94
297. de Andrade DR, de Andrade Junior DR. Typhoid fever as cellular
lnicrobiological model. Rev Inst Med Trop Sao Paulo 2003;45(4): 185-91
!OX. Contrer&s I, Tor0 CS, Troncoso G, Mora GC. Salmonella typhi mutants
defective in anaerobic respiration are impaired in their ability to replicate within
epithelial cells. Microbiology 1997;143 (8):2665-72
299. Vazquez-Toms A, Xu Y, Jones-Carson J, Holden DW, Lucia SM, Dinauer MC,
et al. Salmonella pathogenicity island 2-dependent evasion of the phagocyte
NADPH oxidase. Science 2000;287(5458): 1655-8
3(Kl. Fang F, Vazquez-Tomes A. Salmonella selectively stops traffic. Trends
Microbiol 2002; 10(9):39 1-2
301. Lee AK, Detweiler CS, Falkow S. OmpR regulates the two-component system
SsrA-ssrB in Salmonella pathogenicity island 2. J Bacteriol 2000; 182(3):77 1-8 1
302. Hansen-Wester I. Stecher B, Hensel M. Analyses of the evolutionary
distribution of Salmonella translocated effectors. Infect Immun 2002;70(3):1619-
22
303. Chan K, Baker S, Kim CC, Denveiler CS, Dougan G, Falkow S. Genomic
comparison of Salmonella enterica serovars and Salmonella bongori by use of an
S. enterica serovw typhimurium DNA micromay. J Bacteriol 2003;185(2):553-
63
xxix
References
304. Sarasombath S, Banchuin N, Sukosol T, Rungpitarangsi B, Manasatit S.
Systemic and intestinal immunities after natural typhoid infection. J Clin
Microbiol 1987; 25(6): 1088-93
305. Mastroianni CM, Jirillo E, De Simone C, Grassi PP, Maffione AB, Catino AM,
et al. Humoral and cellular immune responses to Salmonella typhi in patients with
typhoid fever. J Clin Lab Anal 1989;3(3): 19 1-5
306. Salerno-Goncalves R. Wyant TL. Pasetti MF, Fernandez-Vina M. Tacket CO,
Levine MM, et al. Concomitant induction of CD4+ and CD8+ T cell responses in
volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-
htrA. J Immunol2003; 170(5):2734-41
307. Hsu HS. Pathogenesis and immunity in murine salmonellosis. Microbiol Rev
1989;53(4):390-409
308. McSorley SJ, Jenkins MK.Antibody is required for protection against virulent
but not attenuated Salmonella enterica serovar typhirnurium. Infect Immun
2000;68(6):3344-8
309. Mittrucker HW, Raupach 8, Kohler A, Kiufmann SH. Cutting edge: role of B
lymphocytes in protective immunity against Salmonella typhimurium infection. J
lmmunol2000; 164(4): 16-48-52
3 10. Mastroeni P, Simmons C. Fowler R, Hormaeche CE, Dougan G. Igh-6(-I-) (B-
cell-deficient) mice fail to mount solid acquired resistance to oral challenge with
virulent Salmonella enterica serovar typhimurium and show impaired Thl T-cell
responses to Salmonella antigens. Infect Irnmun 2000;68(1):46-53
31 1 . Adversarial sbategies during infection. In: Roitt IM, editor. Roitts essential
immunology. 9' Ed, United Kingdom: Blackwell Science Ltd ;1997. p.253-84
312. Sood A. Kaur IR. Electrophoretic analysis of Salmonella typhi and other
bacteria. Indian J Med Sci 2002;56(6):265-9
313. Tsutsumi R. lchinohe Nu', Shimwki 0 , Obata F, Takahashi K, Inada K, et al.
Homologous and heterologous antibody responses to lipopolysaccharide after
enterohemohagic Escherichia coli infection. Microbiol lmmunol 2004;48(1):27-
38
References
314. ~ o u s e D, Chinh NT, Hien TT. Parry CP, Ly NT, Diep TS, et al. Cytokine
release by lipopolysacchhde-stimulated whole blood from patients with typhoid
fever. J Infect Dis 2002; 186(2):240-5
315. Maswoeni PI Clare S, Khan S, Hamson JA, Hormaeche CE, Okamura H, et al,
Interleukin 18 contributes to host resistance and gamma interferon production in
mice infected with virulent Salmonella typhimurium, Infect lmmun
1%9;67(2):478-83
316. Nauciel C, Espina~se-Maes F. Role of gamma interferon and tumor necrosis
factor alpha in resistance to Salmonella typhimurium infection. Infect lmmun
1992;60(2):450-1
317. Maskell DJ, Hormaeche CE, Hanington KA, Joysey HS, Liew M . The initial
suppression of bacterial growth in 3 salmonella infection is mediated by a
localized rather than a systemic response. Microb Pathog 1987;2(4):295-305
318. Mastroeni P, Arena A, Costa GB, Liberto MC, Bonina L, Hormaeche CE.
Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection
by anti-TNF alpha antibodies. Microb Pathog 1991; l1(1):33-8
319. Mastroeni P, Harrison JA, Robinson JH, Clare S, Khan S. Maskell DJ, et al.
Interleukin-12 is required for control of the growth of attenuated aromatic-
compounddependent salmonellae in BALBlc mice: role of gamma interferon and
macrophage activation. Infect lmmun 1998;66( 10):4767-76
320. Dunstan SJ. Stephens HA. Blackwell JM. Duc CM, Lanh MN. Dudbridge F, et
al. Genes of the class 11 and class 111 major histocompatibility complex are
associated with typhoid fever in Vietnam. J Infect Dis 2001;183(2):261-8
321. D h m a n a E. Joosten I, Tijssen HJ, Gasem MH, Indanvidayati R, Keuter M, et
al. HLA-DRBI*12 is associated with protection against complicated typhoid
fever, independent of tumour necrosis factor alpha. Eur J Immunogenet
2002;29(4):297-300
322. Grossman DA, Witham ND, Burr DH. Lesmana M, Rubin FA, Schoolnik GK,
et al. Flagellar serotypes of Salmonella typhi in Indonesia: relationships among
motility, invasiveness, and clinical illness. J Infect Dis 1995;171(1):212-6
References
323. Liu SL, Ezaki T, Miura H, Matsui K, Yabuuchi E. Intact motility as a
Salmonella typhi invasion-related factor. Infect Immun 1988;56(8): 1967-73
324. Kantele A, Arvilommi H, Kantele JM. Rintala L, Makela PH. Comparison of
the human immune response to live oral, killed oral or killed parenteral
Salmonella typhi TY21A vaccines. Microb Pathog 1991;10(2):117-26
325. Schultz CL. Kaufman B, Hamilton D, Hartman A, Ruiz M, Powell C, et al. Cell
wall structures which may be important for successful immunization with
Salmonella-Shigella hybrid vaccines. Vaccine 1990;8(2):115-20
326. Wyant TL, Tanner MK, Sztein MB. Potent immunoregulatory effects of
Salmonella typhi flagella on antigenic stimulation of human peripheral blood
mononuclear cells. Infect lmmun 1999;67(3): 1338-46
327. Eichelberg K, Galan JE. The flagellar sigma factor FliA (sigma(28)) regulates
the expression of Salmonella genes aqsociated with the centisome 63 type 111
secretion system. Infect lmmun 2000;68(5):2735-43
328. Wyant TL. Tanner MK. Sztein MB. Salmonella typhi flagella are potent
inducers of proinflammatory cytokine secretion by human monocytes. Infect
Immun 1999:67(7):36 19-24
329. Bellanti JA, Eiuman DV, Robbins JB. Smith RT. The development of the
immune response. Studies on the agglutinin response to Salmonella flagellar
antigens in the newborn rabbit. J Exp Med 1%3;117:479-96
330. Plii AP, Koppikar GV, Deshpande S. Role of modified Widal test in the
diagnosis of enteric fever. J Assoc Physicians India 2003;5 19-1 1
331. House D, Wain J, Ho VA, Diep TS. Chinh NT. Bay PV, et al. Serology of
typhoid fever in an area of endemicity and its relevance to diagnosis. J Clin
Microbiol 2001 ;39(3): 1002-7
332. Tannock GW, Blumershine RV, Savage DC. Association of Salmonella
typhimurium with, and its invasion of, the ileal mucosa in mice. Infect lmmun
1975; 1 l(2): 365-70
333. Lyman MB, Stocker BA, Roantree RJ. Comparison of the virulence of 0:9,12
and 0:4,5,12 Salmonella typhimurium his+ trans duct ant^ for mice. Infect Immun
1977;15(2): 491-9
References
protect C3H mice against challenge with virulent Salmonella typhimurium. J
Immunol 1984; 133(2):950-7
344. Honnaeche CE, J O Y ~ ~ Y HS, Desilva L, Izhar M, Stocker BA, Immunity induced
by live attenuated Salmonella vaccines. Res Microbiol 1990; 141(7-8);757-64
345. Tacket CO, Szlein MB, Wasserman SS, Losonsky G, Kotloff KL, Wyant TL, et
al Phau 2 clinical trial of attenuated Salmonella enterica serovar oral live
vector vaccine CVD 908-htrA in U.S. volunteers. Infect. lmmun 2000; 68: 1196-
20 I
346. Koenig S. Hoffmann MK. Bacterial lipopolysaccharide activates suppressor B
lymphocytes. Prw Natl Acad Sci U S A 1979;76(9):4608-12
347. Winchurch RA, Hilberg C, Birmingham W, Munster AM. Lipopolysaccharide-
induced activation of suppressor cells: reversal by an agent which alters cyclic
nucleotide metabolism, lmmunology 1982;45(1):147-53
348. Ortiz V, Is ibi i A, Garcia-Ortigoza E, Kumate J. Immunoblot detection of class-
specific humoral immune response to outer membrane proteins isolated from
Salmonella typhi in humans with typhoid fever. J Clin Microbiol
1989;27(7): 1640-5
349. Aron L, Faundez G. Gonzalez C. Roessler E. Cabello F. Lipopolysaccharide-
independent ndioimmunoprecipita~ion and identification of structural and in vivo
induced immunogenic surface proteins of Salmonella typhi in typhoid fever.
Vaccine 1993;l l(1). 10-7
350. Tang SW. Abubakar S, Devi S, Puthucheary S, Pang T. Induction and
characterization of heat shock proteins of Salmonella typhi and their reactivity
with sera from patients with typhoid fever. Infect Immun 1997;65(7):2983-6
351. Udhayakumar V, Muthukkaruppan VR. Protective immunity induced by outer
membnne proteins of Salmonella typhimurium in mice. Infect Immun
1987;55(3):8 16-2 1
352. Alurkar V, Kamat R, Immunomodulatory properties of porins of some
members of the family Enterobacteriaceae. Infect lmmun 1997;65(6):2382-8
xxxiv
References
353. Negm RS, Pistole TG. Macrophages recognize and adhere to an OmpD-like
protein of Salmonella typhimurium. FEMS Immunol Med Microbial
1998;20(3):191-9
354. Arockiasamy A, Krishnaswamy S. Crystallization of the immunodominant outer
membrane protein OmpC; the first protein crystals from Salmonella typhi, a
human pathogen. FEBS Lett 1999;453(3):380-2
355. Blanco F, lsibasi A, Raul Gonzalez C, Ortiz V, Paniagua J, Arreguin C, et al.
Human cell mediated immunity to porins from Salmonella typhi. Scand J Infect
Dis 1993;25( 1):73-80
356. Sharma P. Ganguly NK, Sharrna BK, Sharma S, Rawal lJ, Saxena SN, et al.
Humoral and cell mediated immune responses to porins of Salmonella typhi. Jpn J
Exp Med 1989:59(2):73-7
357. Muthukkmppan VR, Nandakumar KS, Palanivel V. Monoclonal antibodies
against Salmonella porins: generation and charac~erization. Immunol Lett
1992;33(2):201-6
358. Sharma P, Ganguly NK. S h m a BK. Sharma S, Sehgal K. Specific
immunoglobulin response in mice immunized with porins and challenged with
Salmonella typhi. Microbiol lmmunol 1989;33(7):5 19-25
350. lsibasi A, Oniz V, Varga. M, Paniagua J, Gonzalez C, Moreno J, et al.
Protection against Salmonella typhi infection in mice after immunization with
outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi. Infect lmmun
1088:56( I 1 ):2953-9
360. Klebba PE, Benson SA, Bala S, Abdullah T. Reid J, Singh SP, et al.
Determinants of OmpF porin antigenicity and structure. J Biol Chem
1990;265( 12):6800- 10
361. Singh SP, Singh SR, Williams YU, Jones L. Abdullah T. Antigenic
determinants of the OmpC p r i n from Salmonella typhimurium. Infect Immun
1()95:63(12):4MX)-5
362. Cabello F. Salmonella Typhi infections are also modulated by antibodies.
Tnnds Microbiol 1998;6 (1 2):470- 1
XXXV
References
363. Pandey KK, Srinivasan S, Mahadevan S, Nalini P, Rao RS. Typhoid fever
below five years. Indian Pediatr 1990;27(2): 153-6
364. Chandra R, Srinivasan S, Nalini P, Rao RS. Multidrug resistant enteric fever. J
Tmp Med Hyg 1992;95(4):284-7
365. Dutta TK, Beeresha. Ghotekar LH. Atypical manifestations of typhoid fever. J
Postgrad Med 2001 ;47(4):248-5 1
366. Sinha R, Saha S. Ascites- an under-reported finding i n enteric fever? Indian
Pediatr 2004; 4 1 : 965-6
367. Gotuuo E, Frisancho 0, Sanchez I, Liendo G, Carrillo C, Black RE, et al.
Association between the acquired immunodeficiency syndrome and infection with
Salmonella typhi or Salmonella paratyphi i n an endemic typhoid area. Arch Intern
Med 1991;151(2):381-2
368. Karande SC, Desai MS. Jain MK. Typhoid fever in a 7 month old infant. J
Postgrad Med 1995;4 l(4): 108-9
369. Pany CM, Hien TT. Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J
Med 2002: 347 (22): 1770-82
370. Khosla SN, Goyle N, Seth RK. Lipid profile in enteric fever. J Assoc Physicians
India 199 1;39(3):260-2
371. Butler T, Knight I, Nath SK, Speelman P, Roy SK, Azad MA. Typhoid fever
complicated by intestinal perforation: a persisting fatal disease requiring surgical
management. Rev lnfect Dis 1985:7(2):244-56
372. Khosla SN. Typhoid perforation. J Trop Med Hyg 1977;80(4):83-7
373. Akgun Y, Bac B, Boylu S, Aban N, Tacyildiz I. Typhoid enteric perforation. Br
J Surg 1995;82(11): 1512-5
374. Nguyen QC, Everest P, Tran TK, House D, Murch S, Parry C, et al. A clinical,
microbiological, and pathological study of intestinal perforation associated with
typhoid fever. Clin lnfect Dis 2004;39(1):61-7
375. Chattcrjee H, Jagdish S, Pai D, Satish N. Jayadev D, Reddy PS. Changing
trends in outcome of typhoid ileal perforations over three decades in Pondicherry.
Trop Gastroenterol2001;22(3): 155-8
xxxvi
References
376. Kayabali I, Gokcora IH, Kayabali M. A contemporary evaluation of enteric
perforations in typhoid fever: analysis of 257 cases. Int Surg 1990;75(2):96-100
377. Hosoglu S, Aldemir M, Akalin S, Geyik MF, Tacyildiz IH, Loeb M. Risk
factors for enteric perforation in patients with typhoid Fever. Am J Epidemiol
2004; 160(1):46-50
378. Adesunkanmi AR, Ajao OG. The prognostic factors in typhoid ileal perforation:
a prospective study of 50 patients. J R Coll Surg Edinb 1997;42(6):395-9
379. Aziz M, Qadir A, Aziz M, Faizullilh. Prognostic factors in typhoid perforation. J
Coll Physicians Surg Pak 2005;15(11):704-7
380. Thong KL. Passey M, Clegg A, Combs BG, Yassin RM, Pang T. Molecular
analysis of isolates of Salmonella typhi obtained from patients with fatel and
nonfatal typhoid fever.J Clin Microbiol 1996;34(4):1029-33
381. Massi MN. Shirakawa T, Gotoh A, Hatta M, Kawabata M. Identification and
sequencing of Salmonella entericil serotype typhi isolates obtained from patients
with perforation and non-perforation typhoid fever. Southeast Asian J Trop Med
Public Health 2005;36(1): 118-22
382. Rajagopalan P, Kumar R, Malaviya AN, Immunological studies in typhoid
fever. 11. Cell-mediated immune responses and lymphocyte subpopulations in
patients with typhoid fever. Clin Exp Immunol 1982;47(2):269-74
383. Sarma VN, Malaviyn AN, Kumar R, Ghai OP, Bakhtary MM. Development of
immune response during typho~d fever in man. Clin Exp Immunol 1977;28(1):35-
9
384. Khosla SN, Kumar D, Singh V. Lyrnphocytic adenosine deaminase activity in
typhoid fevers. Postgrad Med J 1992;68(798):268-71
385. Thevanesam V, Arseculeratne SN, Weliange LV, Athauda PK. Cell mediated
and humoral immune responses in human typhoid fever. Trop Geogr Med
1982;34( 1 ): 13-7
386. Abdool Gaffar MS. Seedat YK, Coovadia YM, Khan Q. The white cell count in
typhoid fever. Trop Geogr Med 1992;44(1-2):23-7
xxxvii
References
387. Keuter M. Dhf~nnana E, Kullberg BJ, Schalkwijk C, Gasem MH, seuren L, et
aI. Phospholipase A2 is a circulating mediator in typhoid fever, J Infect Dis
1995; 172(1):305-8
388. Chiu CH, Su LH, He CC, Jaing TH, Luo CC, Lin TY. Perforation of toxic
megacolon in non-typhoid Salmonella enterocolitis spares young infants and is
immune-mediated. Pediatr Surg int 2002;18(5-6):410-2
389. Butler T, HO M. Acharya G, Tiwari M, Gallati H. Interleukind, gamma
interferon, and tumor necrosis factor receptors in typhoid fever related to outcome
of antimicrobial therapy. Antimicrob Agents Chemother 1993;37(11):2418-21
390. Everest P, Wain I , Roberts M, Rook G, Dougan G. The molecular mechanisms
of severe typhoid fever. Trends Microbiol2001;9(7):316-20
391. Rathore AH, Khan IA, Saghir W. Prognostic indices of typhoid perforation.
Ann Trop Med Parasitol 1987;81(3):283-9
392. Kapoor VK, Mishra MC, Ardhanari R, Chattopadhyay TK, Sharma LK.
Typhoid enteric perforations. Jpn J Surg 1985;15(3):205-8
393, Peiris JS, Thevanesam V, Arseculeratne SN, Kumarakulasinghe CB, Edwards
RH. Ileal perforation in typhoid: bacteriological and immunological findings.
Southeast Asian J Trop Med Public Health 1993;24(1 ):I 19-25
394. Rajagopalan P, Kumar R, Malaviya AN. lmmunological studies in typhoid
fever. I. Immunoglobulins, C3, antibodies, rheumatoid factor and circulating
immune complexes in patients with typhoid fever. Clin Exp lmmunol
I98 I:* 1 ):68-73
395. Gaviria-Ruiz MM. Cardona-Castro NM. Evaluation and comparison of different
blood culture techniques for bacteriological isolation of Salmonella typhi and
Brucella abortus. J Clin Micmbiol 1995;33(4):868-71
396, Rubin FA, McWhirter PD, Punjabi NH, Lane E, Sudarmono P, Pulungsih SP, et
al. Use of a DNA probe to detect Salmonella typhi in the blood of patients with
typhoid fever. J Clin Micmbiol 1989;27(5): 1 1 12-4
397. Haque A, Ahmed J, Qurcishi JA. Early detection of tqphoid by polymerase
chain reaction. Annals of Saudi Medicine 1999; 19 (4):337-340
xxxviii
References
398. Hirose K, Itoh K, Nakajima H, Kurazono T, Yamaguchi M, Moriya K, et al.
Selective amplification of tyv (rfbE), prt (AS) , viaB, and fliC genes by multiplex
PCR for identification of Salmonella enterica serovars Typhi and Paratyphi A. J
Clin Microbiol2002;40(2):633-6
399. Hwrfar J, Ahrens P, Radstrom P. Automated 5' nuclease PCR assay for
identification of Salmonella enterica. J Clin Minobiol2000;38(9):3429-35
400. Pany CM, Hoa NT, Diep TS, Wain J, Chinh NT, Vinh H et al. Value of a
single-tube widal test in diagnosis of typhoid fever in Vietnam. J Clin Microbiol
1999;37(9):2882-6
401. Buck RL, Escamilla J, Sangalang RP, Cabanban AB, Santiago LT, Ranoa CP, et
al. Diagnostic value of a single, pre-treatment Widal test in suspected enteric
fever c a e s in the Philippines. Trans R Soc Trop Med Hyg 1987;81(5):871-3
102. Talwar V, Kaur I, Gupta HC. Counter immunoelectrophoresis (CIEP) for
serological diagnosis of typhoid fever, Indian J Med Res 1986;84:353-7
103. Koeleman JG. Regensburg DF, van Katwijk F, MacLaren DM. Retrospective
study to determine the diagnostic value of the Widal test in a 11on-endemic
country. Eur J Clin Microbiol Infect Dis 1992;l l(2): 167-70
104. Olopoenia LA, King AL. Widal agglutination test - 100 years later: still plagued
by controversy. Postgrad Med J 2000;76(892):80-4
105. Hatta M. Goris MG. Heerkens E, Gooskens J , Smits HL. Simple dipstick assay
for the detection of Salmonella typhi-specific IgM antibodies and the evolution of
the immune response in patients with typhoid fever, Am J Trop Med Hyg
2002;66(4):416-2 1
406. Jesudason MV, Sridharan G, Arulselvan R, Babu PG, John TJ. Diagnosis of
typhoid fever by the detection of anti-LPS & anti-flagellin antibodies by ELISA.
Indian J Med Res 1998;107:204-7
407. Cardona-Castro N, Gotuzzo E, Rodriguez M, Guerra H. Clinical application of a
dot blot test for diagnosis of enteric fever due to Salmonella enterica serovar typhi
in patients with typhoid fever from Colombia and Peru. Clin Diagn Lab Immunol
2000;7(2):312-3
xxxix
References
408. Nandakumar KS, Palanivel V, Muthukkanrppan V. Diagnosis of typhoid fever:
detection of Salmonella typhi porins-specific antibodies by inhibition ELISA.
Clin Exp Immunol 1993;94(2):317-2 1
409. Purwaningsih S, Handojo 1. Rihatini, Probohoesodo Y. Diagnostic value of
dot-enzyme-immunoassay test to detect outer membrane protein antigen in sera of
patients with typhoid fever. Southeast Asian J Trop Med Public Health
2001 ;32(3):507-12
410. Verdugo-Rodriguez A, Gam LH, Devi S, Koh CL, Puthucheary SD, Calva E, et
al. Detection of antibodies against Salmonella typhi outer membrane protein
(OMP) preparation in typhoid fever patients. Asian Pac J Allergy Immunol
1993; 1 1(1):45-52
41 1 . lsmail A, Hai OK, Kader ZA. Demonstration of an antigenic protein specific for
Salmonella typhi. Biochem Biophys Res Commun 1991;181(1):301-5
312. Choo KE, Oppenheimer SJ, lsmail AB, Ong KH. Rapid serodiagnosis of
typhoid fever by dot enzyme immunoassay in an endemic area. Clin Infect Dis
1994; 19( 1 ): 172-6
313. Jesudason M, Esther E, Mathai E. Typhidot test to detect IgG & IgM antibodies
in typhoid fever, Indian J Med Res 2002;116:70-2
414. Bhutta 2.4, Mansurali N. Rapid serologic diagnosis of pediauic typhoid fever in
an endemic area: a prospeclive comparative evaluation of two dot-enzyme
immunoassays and the Widal test. Am J Trop Med Hyg 1999;61(4):654-7
115. Choo KE, Davis TM, lsmail A, Tuan lbrahim TA, Ghazali WN. Rapid and
reliable serological diagnosis of enteric fever: comparative sensitivity and
specificity of Typhidot and Typhidot-M tests in febrile Malaysian children. Acta
Trop 1999;72(2): 175-83
416. Jackson AA, Ismail A, Ibrahim TA, Kader ZS, Nawi NM. Retrospective review
of dot enzyme immunoassay test for typhoid fever in an endemic area. Southeast
Asian J Trop Med Public Health 1995;26(4):625-30
417. Chart H, Cheesbmugh JS. Waghom Dl. The serodiagnosis of infection with
Salmonella typhi. J Clin Path01 2000;53(11):851-3
References
418. Franco A, Gonzalez C, Levine OS, Lagos R, Hall RH, Hoffman SL, et al.
Further consideration of the clonal nature of Salmonella typhi: evaluation of
molecular and clinical characteristics of strains from Indonesia and Peru. J Clin
Microbiol 1992;30(8):2 187-90
419. Vullo V, Mastroianni CM, Contini C, Cignarella L, Massetti AP, Falciano M, et
al. lmmunoblot analysis of Salmonella typhi lipopolysaccharjde (LPS) using
typhoid sera. Boll 1st Sieroter Milan 1987;66(2):130-3
420. de Andrade CM, Ferreira AG, da Silva ID, Nascimento HJ, da Silva JG Jr.
Chemical and immunological characterization of a low molecular weight outer
membrane protein of Salmonella typhi. Microbiol Immunol 1998;42(8):521-6
421. Chander H. Majumdar S, Sapru S, Rishi P. Reactivity of typhoid patients sera
with stress induced 55 kDa phenotype in Salmonella enterica serovar Typhi. Mol
Cell Biochem 2004;267(1-2):75-82
422. Mathai E, Jesudason MV. Coagglutination test in the diagnosis of typhoid fever.
Indian J Med Res 1989;89:287-9
423. Kalhan R, Kaur I, Singh RP, Gupta HC. Latex agglutination test (LAT) for the
diagnosis of typhoid fever. Indian Pediatr 1999;36(1):65-8
424. Kang G, Sridharnn G, Jesudason MV, John TJ. Evaluation of modified passive
haemagglutination assay for Vi antibody estimation in Salmonella typhi
infections. J Clin Pathol 1992;45(8):740-1
425. Collee JG. Miles RS. Watt B. Tests for the identification of bacteria. In: Collee
JG, Fraser AG. Mannion BP, Simmons A, editors. Mackie and McCartney
practical medical microbiology. 14th Ed. London: Churchill Livingstone; 1996. p.
131-49
426. National Committee for Clinical Laboratory Standards. Performance standards
for antimicrobial disk susceptibility tests, 6th ed. Approved standard M2-A6.
Wayne. Pa: National Committee for Clinical Laboratory Standards; 1997
427. National Committee for Clinical Laboratory Standards. Methods for dilution
antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed.
Approved standard M7-A4. Wayne. Pa: National Committee for Clinical
Laboratory Standards; 1997
xli
References
428, Fujimoto S, Marshall B. Blaser MJ. PCR-based restriction fragment length
polymorphism typing of Helicobacter pylon. J Clin Microbial 1994;32(2):331-4
429. Sarnbrook J, Fritsch E.F, Maniatis T, editors. Molecular cloning: a laboratory
manual. 3rd Edn. New York : Cold Spring Harbor Laboratory Press; 2001
430. Altschul SF, Gish W, Miller W. Myers EW, Lipman DJ. Basic local alignment
search tool. 1. Molecular Biol 1990; 215:403-10
431. Schnaitman CA. Solubilization of the cytoplasmic membrane of Escherichia
coli by Triton X-100. J Bacterial 1971; 108(1):545-52
432. Sambrook J, Fritsch EF, Maniatis T, editors. Molecular cloning: a laboratory
manual. 2"' Edn. New York: Cold Spring Harbor Laboratory Press; 1989, p.
18.56
433. Costa.~ M. The analysis of bacterial proteins by SDS polyacrylamide gel
electrophoresis. In Howard I, Whitcomb DM, editors. Methods in molecular
microbiology. New Jersey:Humana Press; 1995. p.27-41.Vol 46 Diagnostic
bacteriology protocols.
434. Towbin H. Staehelin T. Gordon J. Electrophoretic transfer of proteins from
polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc Natl Acad Sci U S A 1979;76(9):4350-4
435. Chart H, Rowe B. Cheesbrough JS. Serological response of patients infected
with Salmonella typhi. J Clin Path01 1997;50(11):944-6
436. Lowry OH. Rosebrough NJ, Farr AL, Randall RI. Protein measurement with the
Folin phenol reagent. J Biol Chem 1951 ;193( 1):265-75
437. Dutta S, Sur D, Manna B, Bhattacharya SK, Deen JL. Clemens JD. Rollback of
Salmonella enterica serotype Typhi resistance to chlorarnphenicol and other
antimicrobials in Kolkata. India. Antimicrob Agents Chemother 2005;49(4):1662-
3
138. Bhattacharya SS, Da. U. Occumnce of Salmonella typhi infection in Rourkela,
Orissa, Indian J Med Res 2000,111 :75-6
439. Rasaily R, Dutta P, Saha MR, Mitra U, Lahiri M, Pal SC. Multi-drug resistant
typhoid fever in hospitalised children. Clinical, bacteriological and
epidemiological profiles. Eur J Epidemiol 1994;10( 1 ):4 1-6
xlii
References
440. Yo0 Sq Psi Hp Byeon JH, Kang YH, Kim S, BK, ~ ~ i d ~ ~ i ~ l ~ ~ ~ of Salmonella enterica SerotYPe typhi infections in Korea for recent 9 years: trends
of antimicrobial resistance. J Korean Med Sci 200419(1): 15-20
441. Banikhi MN. Occurrence of Salmonella typhi and Salmonella paatyphi in
Jordan. New Microbiol 2003;26(4):363-73
442. Otegbayo JA, Daramola 00, Onyegbutulem HC, Balogun WF, Opntoye 00.
Retrospective analysis of typhoid fever in a tropical tertiary health facility. Trop
Gastroenterol 2002;23( 1 ):9- 12
443, Senthilkumar B, Prabakaran G. Muitidrug resistant Salmonella typhi in
asymptomatic typhoid carriers among food handlers in Namakkal district, Tamil
Nadu. Indian J Med Microbiol 2005;23(2):92-4
444. Canals M, Labra F. Non linear analysis of infection diseases dynamics in Chile.
Rev Med Chil 1999;127(9): 1086-92
445. Mandal S, Mandal MD, Pal NK. Reduced minimum inhibitory concentration of
chloramphenicol for Salmonella enterica serovar typhi, Indian J Med Sci.
2004;58(1): 16-23
446. Jesudason MV, John R, John TI. The concurrent prevalence of
chloramphenicol-sensitive and multi-drug resistant Salmonella typhi in Vellore, S.
India Epiderniol Infect 1996; 1 16(2):225-7
447. Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant
Salmonella typhi is not associated with increased incidence of antibiotic-
susceptible strain in Bangladesh. Epidemiol Infect 2002;129(1):29-34
448. Ochiai RL, Wang X, von Seidlein L, Yang J, Bhutta ZA, Bhattacharya SK, et al.
Salmonella paratyphi A rates. Asia. Emerg Infect Dis 2005;11(11):1764-6
449. Jesudason MV. Paratyphoid fever in Vellore. South India. Trop Doct.
2005;35(3): 191
450. Chandel DS. Chaudhry R, Dhawan B, Pandey A, Dey AB. Dw-resistant
Salmonella enterica serotype paratyphi A in India. Emerg Infect Dis
2000;6(4):420- 1
451. Sood S. Kapil A, Das B, Pain Y, Kabra SK. Re-emergence of chloramphenicol-
sensitive Salmonella typhi. Lancet 1999;353(9160): 1241-2
xliii
References
452. Takkar VP, Kumitr R, Takkar R. Khurana S. Resurgence of chloramphenicol
sensitive Salmonella typhi. lndian Pediatr 1995;32(5):586-7
453. Srivastava L , Aggarwal P. Mullidrug resistant Salmonella Typhi in Delhi.
Indian J Med Microbiol 1994;12 (2): 102-5
454. Chande C. Shrikhande S, Kapale S, Agrawal S, Fule RP. Change in
antimicrobial resistance pattern of Salmonella Typhi in central India. lndian J
Med Res 2002: I 15:248-50
455. Ranju C. Pais P. Ravindran GD, Singh G. Changing pattern of antibiotic
ensilivity of Snlmonella typhi. Natl Med J India 1998;11(6):266-7
456. Lipitch M. The rise and fall of antimicrobial resistance.Trends Microbiol
?001;9(9):4384
457. Ciutmann L. Williamson R, Moreau N, Kitzis MD, Collatz E, Acar JF, el al.
Cross-resistance to nalidiaic acid. vimcthoprim, and chloramphenicol arsociated
with alterntionr In outer membrane proteins of Klebsiella, Enterobacter, and
Serratia. J Infect Dis 1985; 15 1(3):501-7
458. Siha SK. Talukder SY, Islam M, Saha S. A highly ceftriaxone-resistant
Salmonella typhi in Bangladesh Pediatr Infect Dis J 1999;18(4):387
4.59. Gupa A. Sw;unkar NK. Choudhary SP. Changing antibiotic sensitivity in
cnteric fcver. J Trop Pediav ?001;47(6):369-7 1
1(0 Su CP, Chen YC, Chang SC. Changing chardcleristics of typhoid fever in
Tawan. J Micrthlol lmmunol Infect 2004;37(2): 109- I4
Jhl . Rao KS. Sundwmj 'T. Subramanian S. Shankar V. Mur~y SA. Kapoor SC. A
~ u d y of drug rtbrstance among Salmonella typhi and Salmonella pwatyphi A in
an enJem~c area. 1977-79. Ttans R Soc Trop Mcd Hyg 1981;75( 1):214
462. Kumar R, Aneja KR. Punin AK. Roy P. Sharma M. Gup~a R. el al. Changing
pam of b~otypes. phage types & drug resistance of Salmonella typhi in
Mhiana during 1980-1999. lndian J Med Res 2001;I 13:17580
4 6 3 . ThmlfaJl EJ, W d LR. D e c r d susceptibility lo cipmfloaacin in Salmonella
entaica smype Typhi. United Kingdom. Emerg Infect Dis 2001;7(3):438-50
464. Dutta P, Mitra U, Dutta S, De A, Chatterjee MK. Bhattacharya SK. Ceftriaxone
therapy in ciprofloxacin treatment failure typhoid fever in children. Indian J Med
Res2001;I 13:210-3
465. Ciraj AM. Seema DS, Bhat GK, Shivananda PG. Nalidixic acid screening test
for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
Indian J Path01 Microbiol 200 1 ;44(4):407-8
4th. Hakitmn AJ, Lindgren M, Huovinen P, Jalava J. Siitonen A, Kotilainen P. New
quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-
susceptible isolates with reduced fluoroquinolone susceptibility, J Clin Microbiol
2005;43( 1 1 ):5775-8
467. Sekar U. Srikanth P, Kindo AJ. Babu VP. Rammubramanian V. Increase in
minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae
causing enferic fever. J Commun Dis 2003;35(3): 162-9
468. Clinical and Laboratory Standards Institute (Formerly NCCLS). Performance
standards for antimicrobial susceptibility tehting: 15" international supplement.
CLSUNCCLS document M100-S15. Clinical and Laboratory Standards Institute,
Wayne. Pennsylvania. 2005
469. H~rosc K. Hishimot0 A. Tamura K, Kawamura Y. Ezaki T. Sagara H, et al.
DNA sequence analysis of DNA gym.. md DNA topoisomerase IV quinolone
rcsistmce-determining regions of Salmonella enterica nrovar Typhi and semvar
Ilaratyph~ A. Antimicmb Agents Chemother 2002;46( 10):3249-52
,470. Sh~r~kawa T. Acharya B. Kinoshits S. Kumapa~ S. Gotoh A. Kawabata M.
k c m a d susceptibility to fluoroquinolones and gyrA gene mutation in the
Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu. Nepal.
tn 2003. Diagn Microbiol Infect Dis 2006:54(4):299-303
471. Nair S, Unnikrishnan M. Turner K. Parija SC. Churcher C. Wain J. Harish BN.
Molecular analysis of fluoroquinolone-resistant Salmonella Paratyphi A isolate.
India. Emag Infect Dis 2006; 12(3):489-91
372. Shomidge VD. Stone GG, Flamm RK. k y e r J. Vedov ic J. Graham DW. et
al. Molecular typing of Helicobacler pylori isolales h m a multicenter U.S.
References
clinical trial by ureC restriction fragment length polymorphism. J Clin Microbiol
1997;35(2):47 1-3
473. Hunado A. Owen R1, Identification of mixed genotypes in Helicobacter pylori
from gastric biopsy tissue by analysis of unase gene polymorphisms. FEMS
lmmunol Med Microbiol 1994;8(4):307- 13
474,Some background information about DNA methylation
http:llwww.people.comell.edu lpagedpds28/ Background%20on%2Omethylation.
html downloaded on 13.03.06
475. Schukler D, Lorincz MC, Cimhord DM. Telling A, Fcng YQ, Bouhilcsira EE,
et al. Genomic targeting of methykited DNA: influence of methylation on
transcription, nplication, chromatin structure, and histone acetylation. Mol Cell
Biol2000;20(24):9103- 12
476. Renuka K. Sood S. Das BK, Kapil A. High-level ciprofloxacin resistance in
Salmonella enterica wrotype Typhi in India. J Med Microbiol 2005:54(10):999-
1000.
177. Chu YW, Hwang ET. Chenp AF Novel combination of mutations in the DNA
pyrase and topoisomerase IV penes in laboratory-grown fluoroquinolone-resistant
Shigella f lexmi mutants. Anlimicrob Agents Chemother 1998;42(1 11305 1-2
478. Webber M. Buckley AM. Rnndall LP. Woodward MJ. Piddock U.
O v e r c x ~ i o n of marh, soxS and acrB in veterinary isolates of Salmonella
entenca rarely correliues with cyclohexane tolerance. J Antimicrob Chemother
2OOb;57(4):673-9
479. Wang H. Dzink-Fox J L Chcn M. Levy SB. Genetic characterization of highly
fluoroquinolone-resistant clinical Eschuichia coli strains from China: role of acrR
mutations. Antimicmb Agents Chemother 2001 :45(5): 1515-2 1
480. D i j h h L. Michel MF. Degener JE. Cell envelope protein profiles of
Acinetobscter calcoanticus strains isolated In hospitals. J Med Micmbioi
1987:23(4):313-9
481. timansky AS. Muss1 MA. Vide AM. Loss of a 29-kilodalton outer membrane
protein in Acinetobrrter baumannil is associated with imipenem resistance. J Clin
Micmbiol2002;40( 12):4776-8
References
482. Suzut S, Aparecida T. Gornes T, Guth BE. Characterization of serotypes and
outer membrane protein profiles in enteroaggregative Escherichia coli strains.
Micmbiol lmmunol 1999;43(3):201-5
483. Kline MW. Mason EO Jr, Kaplan SL. Epidemiologic marker system for
Citrobacter diversus using outer membrane protein profiles. J Clin Microbiol
1989;27(8): 1793-6
4X4. Kappos T. John MA. Hussain Z, Valvano MA. Outer membrane protein profiles
and multilocus enzyme electrophoresis analysis for differentiation of clinical
isolates of Proteus mirabilis and Roteus vulgaris. J Clin Microbiol
IW2:3(Y 10):2632.7
48s. Bli~ser MJ. Hopkins JA. Berka RM, Vasil ML. Wang WL. Identification and
charactenration of Campylobacter jejuni outer membrane proteins. Infect lmmun
l983;42( 1 ):?7&)(4
486. Ng I. LIU SL. Sanderson KE. Role of genomic rearrangements In producing
new r ihypcs of Salmonella typhi. J Bacterial 1999:181(1 I L3536-11
487. Medclms AX, O'Brien TF. Rosenberg EY. Nikaido H. Loss of OmpC porin in a
rtmln of Salmnnella typhimurium causcs incna.\ed resistance to cephalosporins
dunng therapy. 1 Infect DIS 1987:156(5):751-7
4x8. Cebn;~n L. Rudriguer JC. Escribano I. Royo G. Characterization of Salmonella
spp, nlutants with reduced fluoroquinolone susceptibility: Impoflance of efflux
pump mechanisms. Chemotherapy ?005;51( 1 ):40-3
489. Cie 8. McDcm)tt PF. Wh~te DG. Meng J. Role of efflux pumps and
topo~somcrar nul la lions in fluoroqu~nolone resistance in Campylobacter jejuni
and Campylobctcr coli. Antimlmb Agents Chemother 2005;49(8):3347-54
JCW. Chn, KE. Ru i f XR. Oppenheimer SJ. Ariffin WA, Lau J. Abraham T.
tiufulnesr of the Widal test In diagnosing childhood typhoid fever in endemic
mils. I PaeJlatr Ch~ld Health 1993;29( 1 ):36-9
J1jI. h m r s ~ BII. LuBnxby JT. Beyer L. Dearlove CE, Shearman DJ. The human
humoral Immune response In Salmonella typhi Ty2la. J Infect Dis
1991;163(?):336-4.5
References
492. Weber B, Hess 0, Enzensberger R, Harms F, Evans CJ, Hamann A, et al.
Multicenter evaluation of the novel ABN Western blot (imrnunoblot) system in
comparison with an enzym~linked immunosorbent assay and a different Western
blot. J Clin Microbiol 1992;30:691-7
493. DePietropaolo DL, Powers JH, Gill JM, Foy AJ. Diagnosis of Lyme disease.
Del Med J 2006;78(1): 1 1-8
494. Schmitt P, Splettstosser W, Porsch-Ozcururnez M, Finke U, Grunow R. A
novel screening ELlSA and a confirmatory Western blot useful for diagnosis and
epidemiological studies of hlhremia. Epidemiol Infect 2005; 133(4):759-66
495. Beck ST. Leite OM. Armda RS, Ferreira AW. Combined use of Western
bloEL1SA to improve the serological diagnosip of human tuberculosis. Braz J
Infect Dis 2005;9(1):35-43
I06 Sambri V. Miuiangoni A. Eyer C, Reichhuber C. Wtschek E, Negosanti M, et
al. Western immunoblotting with five Treponema pallidum recombinant antigens
for serologic diagnosis of syphilis. Clin Diagn lab lmmunol 2001;8(3):534-9
407. Magnarelli LA, Bushmich SL. Sherman BA. Fikrig E. A comparison of
\erolopic tcsts for the detection of serum antibodies to whole-cell and
recombinant Borrelia burgdorferi antigens in cattle. Can Vet J 2004;45(8):667-73
JVX. Nesra J. Chat H. Owen FU. Drasar B. Human *rum antibody response to
Ilclicohactcr pylon whole cell antigen in an institutionalized Bangladeshi
p~pulat~ofl. J Appl Micmbiol 2001;W 1 ):6X-72
JW. Champagne MJ. Higgins R. Fairbrother JM. Dubreuil D. Detection and
chmcteriz~t~on of leptospinl antigens using a h~otinlavidin double-antibody
\;mdwich enryme.linked immunosorbent assay and ~mmunoblot. Can J Vet Res
1991 :55(3):219-45
5tK) . SbrogicrAlmeida ME. Femira LC. Flagellin expressed by live Salmonella
vxcine strains induces disonct antihody responses following delivery via
systemic or mucosal immunization mutes. FEMS lmmunol Med Microbiol
2001;.W3):203-8
501. Chm H. Jenkins C. Thc semdiagnosis of infections caused by Verocytoloxin-
pducing Escherichia coli. J Appl Microbiol 1999;86(5):73 1-40
502. Yokota SI, Ammo KI, Shibata Y, Nakajima M, Suzuki M, Hayashi S, et al.
Two distinct antigenic types of the polysaccharide chains of Helicobacter pylon
lipopolysaccharides characterized by reactivity with sera from humans with
natural infection, Infect Immun 2000;68( 1 ): 15 1-9
503. Chiut H, Scotland SM. Rowe B. Serum antibodies to Escherichia coli serotype
0157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol
1989;27(2):285-90
504. van der Ley P. Kuipers 0. Tommur.sen J. Lugtenberg B. 0-antigenic chains of
lipopolysaccharide prevent binding of antibody molecules to an outer membrane
pore protein in Enterobacteriaceae. Micmb Pathog 1986; 1 ( 1 ):43-9
505. Bmwn A. Hormaeche CE. The antibody response to salmonellae in mice and
humina studied hy ~mmunobloa and ELISA. Microb Pathog 1989;6(6):445-54
506. Jancar S. Sanchez Crehpo M. Immune complex-mediated tissue injury: a
multislcp paradigm. Trends lmmunol 2005;26( 1 ):48-55
